SEARCH

SEARCH BY CITATION

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

The human eye is constantly exposed to sunlight and artificial lighting. Light transmission through the eye is fundamental to its unique biological functions of directing vision and circadian rhythm and therefore light absorbed by the eye must be benign. However, exposure to the very intense ambient radiation can pose a hazard particularly if the recipient is over 40 years of age. There are age-related changes in the endogenous (natural) chromophores (lipofuscin, A2E and all-trans-retinal derivatives) in the human retina that makes it more susceptible to visible light damage. Intense visible light sources that do not filter short blue visible light (400–440 nm) used for phototherapy of circadian imbalance (i.e. seasonal affective disorder) increase the risk for age-related light damage to the retina. Moreover, many drugs, dietary supplements, nanoparticles and diagnostic dyes (xenobiotics) absorb ocular light and have the potential to induce photodamage to the retina, leading to transient or permanent blinding disorders. This article will review the underlying reasons why visible light in general and short blue visible light in particular dramatically raises the risk of photodamage to the human retina.


Abbreviations:
A2E

N-retinylidene-N-retinylethanolamine

A2Eox

A2E oxidation products

A2PE

N-retinylidene-N-retinyl phosphatidylethanolamine

A2PE-H2

dihydro-N-retinylidene-N-retinyl phosphatidylethanolamine

ABCA4

photoreceptor-specific ATP-binding cassette transporter

AMD

age-related macular degeneration

APE

all-trans-retinal-PE Schiff base (N-retinylidene-phosphatidylethanolamine)

atRal

all-trans-retinal

atRol

all-trans-retinol

DMPO

5,5-dimethyl-1-pyrroline N-oxide

DMSO

dimethyl sulfoxide

EPR

electron paramagnetic resonance

GA

geographic atrophy

GSH

glutathione reduced form

GSSG

oxidized form of glutathione

HLE

human lens epithelium

HNE

4-hydroxynonenal

ICG

indocyanine green

IRBP

interphotoreceptor retinoid-binding protein

iso-A2E

13-cis isomer of A2E

LDH

lactate dehydrogenase

LDL

low-density lipoprotein

LF

lipofuscin

MS

mass spectroscopy

MTS

a cell proliferation assay compound, which is bioreduced by cells into a colored formazan product

NFSO

near-field scanning optical microscopy

PCV

polypoidal choroidal vasculopathy

PDT

photodynamic therapy

PE

phosphatidylethanolamine

POS

photoreceptor outer segments

RA

retinoic acid

RDH

all-trans-retinol dehydrogenase

RGR

retinal G protein-coupled receptor

ROS

reactive oxygen species

RP

retinyl palmitate

RPE

retinal pigment epithelium

SAD

seasonal affective disorder

TBARS

thiobarbituric acid reactive substances

TUNEL

terminal deoxynucleotidyl transferase dUTP nick end labeling

UV

ultraviolet radiation (100–400 nm)

UV-A

ultraviolet B (315–400 nm)

UV-B

ultraviolet B (280–315 nm)

UV-C

ultraviolet C (100–280 nm)

y.o.

years old

Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

Aside from the skin, the eye is the organ most susceptible to sunlight and artificial lighting induced damage. Solar radiation exposes the eye to UV-B (280–315 nm), UV-A (315–400 nm) and visible light (400–700 nm) (1). Light is transmitted through the eye and then signals the brain directing both sight and circadian rhythm. Therefore, light absorbed by the eye must be benign. However, under certain circumstances, the eye may be damaged by solar and artificial radiation.

Factors which determine light damage to the eye

The primary factors, which determine whether ambient radiation will injure the human eye are the intensity of the light, the wavelength emitted and received by ocular tissues, and the age of the recipient (2).

UV and visible light intensity  The greater the intensity of light, the more likely it is to damage the eye. Light that may not ordinarily be harmful can do acute damage if it is sufficiently intense. For example, it is well known that the eye can be damaged (temporarily or permanently) by exposure to reflective sunlight from snow (snow blindness), or from staring at the sun during an eclipse (3,4). There is an increase in UV radiation with a thinning of the protective ozone layer (5). Similarly, the eye can sustain damage from artificial light sources that emit UV-A or UV-B (6). Cumulative light damage results from less-intense exposure over a longer period of time and is often a result of an underlying age-related loss of antioxidant protection (7,8).

Ambient radiation wavelength  Ambient radiation, from the sun or from artificial light sources, contains varying amounts of UV-C (100–280 nm), UV-B, UV-A and visible light (1). The shorter the wavelength, the greater the energy and therefore the greater the potential for the radiation to do biological damage. However, although the longer wavelengths are less energetic, they more deeply penetrate ocular tissues (9).

For a photochemical reaction to occur, the emitted wavelengths of light from the source must be absorbed in a particular ocular tissue. The primate/human eye has unique filtering characteristics that determine in which area of the eye each wavelength of light will be absorbed (Fig. 1). All radiation below 295 nm is filtered by the human cornea (all UV-C and some UV-B) before they reach the human lens (10). The transmission characteristics of the human lens changes with age.

image

Figure 1.  UV and light transmission in the adult human eye. The cornea absorbs UV radiation at wavelengths shorter that 295 nm. A part of UV-B (λ > 295 nm) and UV-A transmitted by the cornea is absorbed by the lens. Only visible light reaches the retina.

Download figure to PowerPoint

In adults, the lens absorb UV-B above 295 nm and all of UV-A. However, the very young human lens transmit a small window of UV-B light (320 nm) to the retina, whereas the elderly lens filters out much of the short blue visible light (400–500 nm) (11). Transmission characteristics through ocular tissues also differs with species; the lenses of mammals other than primates transmit ultraviolet light longer than 295 nm to the retina (12).

Antioxidant system efficacy  Most damage by ambient light to the young and adult eye is avoided because the eye is protected by a very efficient antioxidant system. In addition, there are protective pigments located in the young and adult retina and lens, which absorb ambient radiation and dissipate its energy without causing damage (13).

Ordinarily lutein and zeaxanthan in the macular (center) of the retina (14), vitamin E (15,16), glutathione (7) and other antioxidants (17) throughout the eye protects the retina against both inflammatory and photooxidative damage.

Unfortunately with age, these protective agents become depleted. After middle age (40-year old) there is a decrease in the production of ocular antioxidant enzymes and low-molecular weight antioxidants and the retina loses its protection against reactive oxygen species (ROS) toxicity (7,18,19). In addition, the content and function of cardiolipin which facilitates retention of cytochrome c in mitochondria, preventing the cells from apoptosis diminishes progressively in humans with age to the level constituting ca 60% of the value detected in children (20).

The RPE and choroid contains melanin, which absorbs UV and short-wavelength visible light and protects the retina against photic damage. However, with age ocular melanin is photobleached and this decreases its protective effectiveness against UV damage (21).

At the same time, the protective pigments are chemically modified and now these ocular pigments damage the lens and retina on exposure to ambient radiation (21–23).

Mechanism of light damage to the eye

The role of chromophores  Chronic exposure to less-intense radiation does damage to the eye through a phototoxidation reaction. In such type of oxidation reactions, a chromophore in the eye absorbs UV or visible light, produces ROS such as singlet oxygen and superoxide and these damage ocular tissues. The chromophore may be endogenous (natural) or exogenous (drug, herbal medication or nanoparticle) that has accumulated in the eye (24).

Absorption of light excites the chromophore to a transient singlet state (Fig. 2). The excess of energy of the chromophore singlet state can be dissipated (13), emitted as fluorescence or used for intersystem crossing to the triplet state. The chromophore can return to its ground energy level by dissipation of the excess of energy or phosphorescence. The chromophore lifetime at triplet state is long enough to let its molecules transfer electrons via a Type I and form free radical or the excess of energy via a Type II to different molecules, for example oxygen and produce its singlet form (singlet oxygen). The reactive species generated during these processes can cause the eventual damage. Photooxidation can occur in the eye either by Type-I or -II mechanism or both concurrently.

image

Figure 2.  The scheme of photosensitizing reactions. Absorption of UV or light () by a photobiologically active endogenous or xenobiotic chromophore (photosensitizer) excites the chromophore from its ground state (1S), which is typical for most biologically relevant molecules to a transient singlet state (1S*) and then by intersystem crossing (ISC) to the triplet state (3S*). The chromophore lifetime at triplet state is long enough to let its molecules either transfer an electron (Type I) to or from a molecule of other compound (R) present in the environment of the raction and form free radicals. If oxygen is present in the solvent in which the photosensitizing process is running (air or oxygen saturated), an electron is transferred from 3S* to an oxygen molecule, which ground state is a triplet (3O2) and a photosensitizer radical cation (S•+) and superoxide anion (O2•−) are produced. Superoxide anion can be converted to H2O2 by superoxide dismutase enzymes and also by autodismutation reactions. In the presence of free or weakly chelated iron or copper ions, H2O2 molecules are decomposed yielding hydroxyl radicals (OH). This form of oxygen radical is very reactive and can abstract proton from an unsaturated fatty acid molecule to form an alkyl radical (L). The excited triplet state of a photosensitizer (3S*) can return to its ground form (1S) by transfer of excess of energy to a molecule of oxygen (Type II) to produce its singlet form (1O2). Singlet oxygen can oxidize unsaturated fatty acids or cholesterol and generate their hydroperoxides. The reactive oxygen forms generated during these processes can cause the eventual damage to tissues. They are able to oxidize proteins and DNA. These reactions (photooxidation) can occur in the eye by either a Type-I or -II mechanism or both concurrently.

Download figure to PowerPoint

Human retina  The retina in the mammalian eye is composed of the photoreceptor cells (rods and cones) that receive light and the neural portion (ganglion, amacrine, horizontal and bipolar cells) that transduces light signals through the retina to the optic nerve. Behind the photoreceptor cells are the retinal pigment epithelial (RPE) cells, which are separated from choroid with Bruchs’ membrane.

RPE cells  The RPE cells form a single-cell layer that is the most distal layer of the retina. The cells transport ions, water and metabolic end products from the subretinal space to the blood (25), and deliver nutrients, such as glucose, retinol and fatty acids in the opposite direction—from the blood to the photoreceptors. Moreover, the RPE cells phagocyte light-damaged photoreceptor outer segments (POS) (26) in a circadian regulated process, and then shed, digest, recycle and transport the essential elements of their contents back to the photoreceptors (25,27). However, a part of undigested material accumulates with age and is stored in lysosomes as an age pigment called lipofuscin (28) (Fig. 3).

image

Figure 3.  Lipofuscin distribution in the human RPE cells in a young person (A) and in an old individual with pre-AMD symptoms (B). The single-cellular layer of RPE cells connected to each other with tight junctions (TJ) is separated from the choroid (Ch) with Bruch’s membrane (BrM). The RPE cells of a young person show characteristic internal compartmentalization, where melanosomes (Ms) are present mostly in the apical layer protecting deeper situated organelles from excess of light. Mitochondria (Mt), however, are gathered mostly in the basal layer closer to the choroid. Undigested components of used up photoreceptor outer segment (POS) disks phagocytosed by the RPE cells are stored below the Ms layer closer to the nucleus (N) in autofluorescent granules called lipofuscin (Lf). During lifetime the number of Lf granules increases and a part of them forms aggregates with melanosomes called melanolipofuscin (Mlf). At the same time, the number of Ms and Mt decreases (62) and anatomical changes in Mt are observed—they become more round and loose their characteristic cristae structure (272). In addition in some cases, deposits and drusen (Dr) accumulate in BrM and form a barrier for nutrient transportation from choroid to the RPE cells, which can lead to AMD development.

Download figure to PowerPoint

The RPE cells are permanently exposed to factors that potentially induce oxidative stress. Those conditions assure that RPE cells contain high amounts of antioxidant enzymes, such as superoxide dismutase and catalase (25). In addition, the presence of aldehyde dehydrogenase was affirmed in the RPE cells (29). This cytosolic enzyme participates in the oxidation of various aldehydes, including all-trans-retinal. It was shown by Ishibashi et al. (30) that the expression of aldehyde dehydrogenase 6 was reduced in the retinal pigment epithelial cells isolated from older human eyes.

UV damage and “blue light hazard”  The young retina is at particular risk for damage from UV exposure because the young lens has not as yet synthesized the yellow chromophore (3-hydroxykynurenine and its o-β-glucoside) that prevents UV transmission to the retina (31). UV damage to the eye is cumulative and may increase the possibility of developing eye disorders (ocular melanoma and macular degeneration) later in life.

In addition to UV damage to the young retina, short blue visible light (430 nm) damages the retina in persons over 50 years of age through photooxidation reactions (2,32–34). The human retinal pigment epithelium (RPE) and the anterior layers of the retina in adults constantly receive intense visible light (>400 nm) (35,36) (Fig. 1). Studies performed on animals including primates have shown that short-term light exposures (<12 h) at relatively high intensity can induce damage in photoreceptors and the RPE cells (33,37,38). The most phototoxic effect was produced by light at wavelengths around 430 nm, then referred as the “blue light hazard” (39,40). Agarwal et al. (41) observed that thickness of the retinal outer nuclear layer, photoreceptor segment length and RPE thickness were 60–70% reduced when rat retinas were evaluated 4 weeks after blue light exposure. Light damage observed in rats resulted in a retinal degeneration exhibiting features of atrophic age-related macular degeneration (AMD), including photoreceptor and RPE degeneration and choriocapillaris atrophy (38). The most recent experiments demonstrated that 6–h blue light (450 nm) exposure of rats caused significant shortening of the photoreceptor inner and outer segment lengths, when retinas were evaluated immediately after irradiation (33). In addition, 40–50% of the photoreceptor nuclei were pyknotic with condensation of chromatin and dark staining nuclei.

The photodamage observed in the RPE cells is oxygen-dependent (42,43) and is diminished by antioxidants (15,31,44,45), which suggests that the blue light effect is associated with oxidative stress. The dramatic changes observed in the photoreceptors and the RPE after light exposure made investigators to find potential chromophores that would be able to absorb light in the blue region and convert excessive energy to production of reactive intermediates. Photoreceptor damage may be mediated through rhodopsin, as blue light (403 ± 10 nm) causes its photoreversal bleaching and increased generation of toxic rhodopsin intermediates (46,47). There are several endogenous RPE chromophores, including melanin, the mitochondrial enzyme cytochrome c oxidase and riboflavin that can act as potential photosensitizers and may be responsible for visible light short-wavelength damage to the RPE (48,49). The reduced form of cytochrome c oxidase absorbs mainly blue light with a maximum at 440 nm (50). Blue light (425 ± 20 nm) can induce generation of ROS by mitochondrial cytochromes (51), inhibit cytochrome c oxidase leading to ATP depletion (52,53), and lead to calcium accumulation (54) and apoptosis (55).

Nevertheless, photoreactivity of melanin, cytochrome c oxidase or riboflavin present in the RPE seems to be negligible compared with a visual cycle retinoid—all-trans-retinal (56–58) or chromophores present in the age pigment—lipofuscin accumulated in age in the RPE cells (59–62).

Macular degeneration  The relatively high concentration of oxygen in the retina, exposure to light, age-related changes in the level of antioxidants and the presence of chromophores formed during lifetime in situ or xenobiotics create favorable conditions for oxidative stress (36), which can be a major factor of retinal diseases including macular degeneration.

AMD is the major cause of visual impairment and blindness (63,64) among the elderly in the United States and in European and Australian (Oceanic, Pacific) nations (65–70). It is estimated that more than 1.5% of caucasians at age more than 70 years old suffer advanced form of AMD and another 10% have symptoms of early macular degeneration (64,70). AMD is the disease involving photoreceptors, RPE and the choroid in the elderly eyes. It is initially characterized by thickening of Bruch’s membrane and accumulation of lipid material (drusen) on the inner collagenous layer of the membrane (70) (Fig. 3B). The early stages of AMD can evolve into “wet” form, where blood vessel proliferation is observed or to geographic atrophy (GA) associated with the RPE cell death.

Little is known about AMD etiology. However, several risk factors, namely: aging, tobacco smoking, female gender, hypertension, high-body mass index, a high fat diet and some genetic predispositions are considered as those that can contribute to development of the disease (70–73). Sunlight is an environmental factor that has been identified (39,74), but epidemiologic studies assessing the link between light exposure and AMD have provided inconsistent results. Three cohort based studies (34,75–78) showed an association; case control studies (79,80) failed to confirm this relationship, but the age-related eye disease study (AREDS) (81) did suggest a connection between increased light exposure and AMD. An improved study (AREDS2) is presently being conducted (82). In epidemiological studies performed on 4000+ participants, Fletcher et al. (83) found associations between blue light exposure and development of early stages of AMD as well as its neovascular form in persons who had low levels of antioxidants (vitamin C and E, zeaxanthin) in their blood and low uptake of dietary zinc. Indeed, the role of antioxidants seems to be considerable in AMD. Epidemiological studies have shown that, although there is no evidence that supplementation of antioxidants important in the retina metabolism (lutein, zeaxanthin, vitamin C and E and zinc) (14) prevents early AMD development, but it slows down progression to advanced AMD (81,84). Therefore, oxidative stress seems to be the major mechanism involved in development of the disease (85,86).

Endogenous Chromophores

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

Lipofuscin

Increased accumulation of fluorescent age pigment (lipofuscin) is observed in the RPE cells, especially in the rim of the geographic atrophy area. The role of lipofuscin and its photosensitizing chromophores in AMD development is still under debate. The accelerated accumulation of lipofuscin is also observed in a juvenile form of macular degeneration called Stargardt’s disease (87). The toxic effect of lipofuscin components in this disease is particularly visible.

Lipofuscin (LF) is a heterogenic material (88,89), which accumulates with age in lysosomal storage bodies generally in postmitotic cells (90–92), such as neurons, cardiac myocytes, striated muscle fibers, Sertoli cells in testes and RPE (88,93,94). Although morphology of the granules varies from one tissue to another (93), they are formed mostly of non completely digested biomolecules, such as proteins and lipids (88). Interestingly, the pigment exposed to UV irradiance emits fluorescence (93). The mechanism of LF formation and accumulation still remains obscure. It is suggested that oxidative stress, diminished activity of lysosomal proteolytic enzymes, not efficient phagocytosed and/or autophagocytosed material degradation and elimination from the cells are the main factors of lipofuscinogenesis (88,94,95).

LF amount and distribution

Lipofuscin in RPE cells  Lipofuscin in the retinal pigment epithelial cells appears as yellow–brown granules, which are brighter than melanosomes (96) with roughly spherical shape at diameter of 0.5–1 μm (89,93,96–99) and are made up of smaller aggregates at size ca 50 nm (99–101).

The cells that form the RPE are postmitotic cells. That fact has a fundamental significance in lipofuscin accumulation in the aging human eye (62,86,93,102,103) (Fig. 3). The electron microscopy images revealed that the RPE cells in infants contain no recognizable amount of LF (93). At 40 years of age LF granules are present in the subapical cytoplasm. In sixth decade of life the number of the age pigment granules equals or is even higher than the number of melanosomes and progressively increases in age. At the age of 70–80 y.o., LF granules can occupy 19–33% of cytoplasmic volume (60,103). Interestingly, the age pigment granules accumulate in young persons mostly in the basal cytoplasm and LF concentration is ca 1.4 times higher than in the apical part and is reversibly correlated with melanin distribution (104). In older persons, however, the granule distributions of both pigments become more uniform (103). In addition, a conglomerate of melanolipofuscin is accumulated (60,105) with melanin core and LF forming the outer layer (96,106) (Fig. 3B).

Distribution in the eye fundus  Spectroscopic measurements performed on human retinas by Delori et al. (103) showed that LF distribution in the eye fundus is not homogenous (Fig. 4A). Autofluorescence detected in the fovea was ca 40% lower than in the surrounding region (7° eccentricity) and was asymmetrically distributed around the fovea with maxima at ca 7° nasally, 13° superiorly, 11° temporally and 9° inferiorly (103). Interestingly, the intensity of LF autofluorescence was less along inferior meridian than along any other (103). In addition, studies performed on rhesus monkeys showed that lipofuscin autofluorescence is reversibly associated with drusen distribution (107). Autofluorescence detected in the RPE cells over “the dome” of a druse was considerably weaker that from the cells adjacent to the druse. However, a close relationship between drusen formation in the Bruch’s membrane and slower lipofuscin accumulation has not as yet been definitively proven. Moreover, there has been no evidence so far of material characteristic for proteins specific for POS or lysosomal enzymes in Bruch’s membrane drusen (108,109).

image

Figure 4.  Lipofuscin and A2E spatial distribution in the RPE layer. (A) Autofluorescence in the right human eye fovea of old person without AMD symptoms (based on [103]). The maximum of fundus autofluorescence was detected in some distance from the fovea (in the center) from 7° between the fovea and the optic nerve (gray circle) to 13° in the superior side. (B) Lipofuscin (Lf) and A2E spatial distribution in Abca4−/− mouse RPE (based on [180]). There is a good correlation between A2E and Lf spatial distribution in the mouse RPE. Autofluorescence (Af) and A2E in 2-month old mice were detected mostly in the center of the fundus, while in the 6-month old ones the chromophores were distributed in almost entire retina. However, the area of the highest intensity of Af and A2E content formed a ring around the optic nerve.

Download figure to PowerPoint

Association with eye diseases  Enhanced accumulation of LF in the RPE layer is associated with a several retina diseases, such as AMD, Stargardt’s disease, Best’s macular degeneration and Batten’s disease (98,103). Increased LF autofluorescence is clinically observed in the band of the human retina surrounding the region of geographic atrophy (110,111). It could suggest the association between the excessive LF accumulation and RPE cells and their death in the late stage of dry AMD.

Lipofuscin granule composition

Material that forms lipofuscin in the RPE cells originates mainly from the photoreceptor outer segment disks, which are shed on the apical surface of the RPE cells then phagocytozed and exposed to enzymatic digestion in the phagolysosomal system (92,112,113). However, a part of the phagocytosed material originated mostly from peroxidized POS is not entirely digested and accumulates inside the RPE cells forming the age pigment (94,108,113). The impairment of lysosomal degradation in autophagy of used up intracellular organelle, such as mitochondria, Golgi apparatus or endoplasmic reticulum can also contribute in lipofuscin accumulation in the RPE cells (62).

Oxygen effect  Oxygen concentration seems to have considerable significance in LF formation in RPE cells, which are located in the region of high O2 tension (ca 70 mmHg) (48,62). In vitro studies have shown that increased oxygen partial pressure caused enhanced LF accumulation in RPE cells fed with native POS (114). In addition, high oxygenation facilitates peroxidation processes inside the RPE cells and in their close neighborhood. The RPE cells, which phagocytosed POS peroxidized or modified by lipid peroxidation products, accumulated much more LF than cells treated with native POS (94,115).

Role of antioxidants and vitamins  Antioxidant and vitamin level in cell culture medium or animal diet is another factor in the rate of LF accumulation in the RPE cells. Carotenoids (zeaxanthin and lutein) and α-tocopherol significantly reduced LF formation in the RPE cells in vitro (114). A number of studies performed on animals showed that deficiency of antioxidant nutrients, particularly vitamin E in diet caused dramatic accumulation of lipofuscin-like autofluorescent pigments in the RPE (113). It could be an important factor of lipofuscinogenesis in vivo since age-related decline in vitamin E levels in the macular RPE in persons older than 70 (48). On the other hand, the content of vitamin A in the diet is reversibly correlated with LF accumulation in the RPE of tested animals. Vitamin A shortage in the diet significantly reduced formation of the age pigment (113), but the diet supplemented with the retinoid enhanced LF build-up (116).

Proteins in lipofuscin  The age pigment granules in the RPE cells are composed of lipids (20–50%) and proteins (30–70%) (99,117–120). The usage of proteinase K for digestion of the extra-granular material followed by proteomic analyses revealed that lipofuscin contains up 2% proteins, whereas amino acids in the granules non treated with the enzyme accounted for <10% of the dry mass (89,121). The recent studies performed by Biesemeier et al. (96), where an energy-filtered analytical transmission electron microscopy was used seem to prove previous analyses. The mole fraction of nitrogen in human LF granules is at the range of 0.4–1.7 at% and is twice lower compared with cytoplasm, while oxygen mole fraction is 3.6–4.8 at% and at 1/3 higher than in cytoplasm. It could suggest that amino acid content in LF is smaller than in cytoplasm and lipid level is much higher. Most proteins detected in LF were structural proteins associated with membranes, proteins of lysosomal and mitochondrial origin and those typically present in POS like rhodopsin (89,99). Significant amount of proteins in LF has been oxidatively modified (89,120,121) by lipid peroxidation product, such as malondialdehyde or 4-hydroxynonenal (HNE) and advanced glycation end products (62,119,122).

Lipids in lipofuscin  Biesemeier et al. (96) studies have shown relatively high phosphorus content in LF granules in the RPE cells, which implies that phospholipids make a significant fraction of all lipids in the age pigment. These suggestions are consistent with results obtained earlier by Haralampus-Grynaviski et al. (101) in mass spectroscopy studies of LF extracts, where phosphatidylcholines and phosphatidylethanolamines of palmitic, stearic, oleic and arachidonic acid were identified with no evidence of docosahexaenoic acid, which is present at high abundancy in POS. Sparrow and Boulton (123) suggest that as the fatty acid composition of POS is different than lipofuscin, the phospholipids extracted from LF granules originate from the phospholipid bilayer surrounding LF body than from phagocytosed POS.

Retinoids in lipofuscin  Phagocytosis of POS disks by RPE cells indicated that lipofuscin cells have specific components compared to the age pigment in different tissues. Beside proteins engaged in the visual cycle, the age pigment granules contain retinoid chromophores (92,105,112,124).

Fluorescence

Lipofuscin in the human RPE cells emits characteristic golden-yellow fluorescence. However, the fluorescence emission spectrum depends on the wavelength of excitation (101,124,125). RPE lipofuscin granules excited at 364 nm exhibit a strong broad band emission spectrum with a peak at 600 nm (91).

Spectrum characteristics  Detection of bulk LF fluorescence revealed that with increasing excitation wavelength from 400 to 532 nm, emission spectrum narrowed, its maximum shifted to the longer wavelengths, but the red arm of the spectrum stood still (101) (Table 1). It suggests that LF is a mixture of numerous fluorophores. Human retinal fundus autofluorescence detected in almost 150 persons when excited at 430 nm showed emission spectrum with maximal intensity at 608 ± 1 nm. Shifting of excitation wavelength to 545–550 nm caused the peak of emission spectrum to move to 630–640 nm (103,124). In reverse, when emission of LF from RPE cells was set up 610 nm, the excitation spectrum was characterized by two peaks—the main at ca 480 nm and a secondary at 405 nm (120).

Table 1.   Spectrophotometric characteristics of lipofuscin and ocular retinoids.
ChromophoreOcular distributionAbsorbanceFluorescenceReferences
Peak (nm)SolventExcitation wavelength (nm)Emission wavelength (nm)Solvent
RangePeak
  1. Abs, absorbance; Af, autofluorescence; DCM, dichloromethane; Fl, fluorescence; Lf, lipofuscin; MeCN, acetonitrile; MeOH, methanol; OD, ocular distribution; OS, outer segments; POS, photoreceptor outer segments; TrX-100, Triton X-100; wr, wavelength range; (?), the presence has not been absolutely proven.

LipofuscinRPE  364broad band600 (91)
   Increasing from 400 to 532Narrowing with “red arm” standing stillShifting to longer wavelengths (101)
   405, ca 480 610 (120)
   430 (Af) 608 (103,124)
   458550–645  (98)
   545–550 (Af) 630–640 (103)
all-trans-retinalPOS; Phagocytosed POS in RPE (?)382 (wr: 280–450)   467 (35,150) (56,158)
A2EPOS (?) Lf in RPE336, 430–439 380 565–570RPE cellsOD: (102,103,166,170,172,176) Abs: (168,173,190) Fl: (169)
   380585–610 Organic(169)
   400550–590 Liposomes(191)
   430510–570 Organic(173)
   430 615TrX-100 micelles(173)
APEPOS456MeCN    (166,170,171)
HIDDA2E synthetic analog360–370MeCN   ca 520DCM(206)
HIDD-H+A2E synthetic analog ca 450MeCN   ca 610DCM(206)
A1EA2E synthetic analog417MeOH  560 (207)
A2PE-H2POS; phagocytosed POS in RPE205, 500     (166)
A2PEPhagolysosomes in RPE POS (?)330, 430 337, 456MeCN Orange  (166,183) (170–172)
A2-RhBovine rod OS      (208)
atRal dimer (AD)Rod OS295, 432     (209)
AD-PERod OS285, 506     (209–211)
A2-DHP-PEBovine and human RPE330, ca 490     (211)
A2-GPE Abca4 −/− mouse eyes338, 443     (215)
Mono- to tetra-oxygenated A2E productsLf in RPE295–340, 400–440 (wr <550)     (200–202)

Changes with age  Spectroscopic studies showed that optical density and fluorescence intensity of LF granules increases with age (39,126). The spectrum of LF fluorescence is slightly different in young and elderly persons. The blue component of the fluorescence spectrum is observed only in the granules extracted from young persons (126,127). However, the blue band is absent in LF from old persons and the intensity of yellow and orange bands is significantly enhanced. The diversity in fluorescence spectra between LF granules was confirmed using near-field scanning optical (NFSO) microscopy (98). The LF isolated from 60 to 90 y.o. persons excited at 458 nm showed varied fluorescence emission spectra between individual granules with maxima in range 550–645 nm. The images taken with NFSO and atomic force microscopy showed nonhomogenous distribution of orange fluorophores in LF granules, whose surface can be partially even non emissive (97,100).

The effect on RPE cell metabolism

The age pigment accumulated in the RPE cells seems to have a negative effect on metabolism of the cells. Studies performed in vitro on RPE cells isolated from newborn pigmented rabbits showed that overloading of the cells with peroxidized POS (artificial lipofuscin) caused reduced phagocytotic capacity (88,114). Similar effect was observed in human fibroblasts. The cells first stimulated for accumulation of ceroid/lipofuscin then exposed to oxidative stress showed increased susceptibility to oxidative damage (128). However, diminished autophagocytosis and decreased survival time was observed in the cells preloaded with ceroid/lipofuscin and then starved with essential amino acids (128).

Photoreactivity

The age pigment present in the human RPE cells shows broad reactivity when exposed to UV or short-wavelength visible light. The RPE cells isolated from human donors exposed to blue light (408–495 nm) in vitro showed substantial oxygen consumption, which rate correlated with the age of donors suggesting a major role of LF in age-related photodamage of the retina (59).

Transient species  Indeed, photoexcitation of the extracts of human LF in organic solvents led to formation of transient species: LF triplet state observed at 430–440 nm with lifetime 7 and 10.3 μs for LF fractions soluble in chloroform and then dissolved in methanol (129) and LF fraction soluble in hexane and benzene (60), respectively. Another transient species postulated as a free radical insensitive to oxygen were detected and their spectrum had maximum at 580 nm (129).

Oxygen photoconsumption  The transient species photogenerated in LF extracts can interact with oxygen to produce its reactive forms. The electron spin resonance oximetry, in which photoinduced changes of oxygen concentration is measured revealed that action spectrum of O2 uptake in LF granules, its organic solvent extracts and LF insoluble material monotonically decreases with excitation wavelength and are similar to LF absorbance spectrum (61).

ROS photogeneration  Oxygen photoconsumed by LF or its extract is at least partially converted into ROS. The electron paramagnetic resonance (EPR) spin trapping studies revealed that components of human LF extracted by chloroform and irradiated at λ > 300 nm produce superoxide anion, carbon-centered radicals and can abstract hydrogen or electron from methanol used as a solvent to yield hydroxymethyl radical, methoxyl radical cation and hydroxymethyl peroxyl radical (130) (Table 2). Photophysical studies performed on purified age pigment granules isolated from human RPE cells showed that visible light (400–730 nm) illumination induces LF to generate superoxide anion, hydrogen peroxide and singlet oxygen (59,60,105,131). The ROS were photogenerated by LF most efficiently in the blue region (400–520 nm) of the light spectrum (131). However, in vitro studies showed that in contrast to RPE melanosomes, no more than 3% of oxygen photoconsumed in the presence LF was converted into H2O2 (105).

Table 2.   Reactive oxygen species photogenerated by lipofuscin and ocular retinoids.
ChromophoreReactive forms photoproducedReferences
FormIrradiation wavelength (nm)Quantum yield (Φ)Solvent
  1. CCR, carbon-centered radical; C6D12/(CD3)2CO, deuterated cyclohexane and deuterated acetone mixture; deox., deoxygenated; λirrad, irradiation wavelength used for reactive form generation.

  2. *The rates for 1O2 quenching have been determined as ca 3 × 107 m−1 s−1 and 2 × 108 m−1 s−1 in CCl4 (198) and acetonitrile (174), respectively.

LipofuscinO2˙, CCR>300  (130)
O2˙, H2O2, 1O2  400–730  (59,60,105,131)
1O2  300–450 Deuterated chloroform(133)
1O2  3550.08 ± 0.03Benzene (air)(60)
1O2  420–4400.05 ± 0.01Benzene (air)(60)
1O2  420–550 Hexane, benzene(60)
All-trans-retinalCCR>300 Deox. methanol(159)
O2˙  407 DMSO/benzene mix(57)
1O2 0.05Methanol(159)
1O2 0.25Carbon tertrachloride(159)
1O2  3550.16–0.24Benzene(60)
1O2  420–4400.10–0.30Benzene(60)
A2E*O2˙  4070.0003DMSO/benzene mix(61)
1O2 0.02Acetonitrile(190)
1O2  3550.013C6D12/(CD3)2CO(195)
1O2  4200.004Hexafluorobenzene(195)
1O2  4350.004Carbon tertrachloride(174)

Singlet oxygen photoproduction  Photogeneration of 1O2 by LF extract in benzene as well as chloroform-insoluble fraction is wavelength dependent (60,132,133) (Table 2). Avalle et al. (133) showed that LF fraction extracted with mixture of CHCl3:CH3OH:H2O (1:1:1), reconstituted in CDCl3 and exposed to UV–VIS light (300–450 nm) produced singlet oxygen, with an action spectrum characterized by a single band in the range of 300–450 nm with a maximum at 380 nm. However, Różanowska et al. (60) observed that efficiency of 1O2 photogeneration of LF extracts in hexane, benzene or the Folch mixture decreases monotonically with increasing excitation wavelength in range 420–550 nm and is 10 times higher at 420 nm compared with 520 nm. The quantum yields for 1O2 photogeneration in air-saturated benzene is 0.08 ± 0.03 at 355 nm and 0.05 ± 0.01 in blue light (420–440 nm). Singlet oxygen photogeneration by LF is oxygen-dependent—the quantum yield is almost twice higher in benzene solution saturated with oxygen. The authors of the studies suggest that this effect can indicate the possible presence of several photosensitizers, with different lifetime of their triplet states that might transfer energy to molecular oxygen (60). The quantum yield of 1O2 photoformation by LF extract is comparable to all-trans-retinal in methanol (129), whereas in benzene it is two to three and three to six times lower when excited at 355 nm and blue light (420–440 nm), respectively (60) (Table 2). On the other hand, still measureable amounts of singlet oxygen can be photoproduces in LF extract solution at 470 nm, whereas in all-trans-retinal that wavelength is out of range for 1O2 generation.

Lipid and protein peroxidation  In addition, lipofuscin-related photoproduction of lipid hydroperoxides and TBA reactive species indicate that the age pigment exposed to blue light (408–495 nm) enhances lipid peroxidation in the human RPE cells (59). Human LF granules exposed to visible light (408–495 and 515 nm) caused lipid peroxidation in vitro (105,134) in the human RPE cell culture and in the POS isolated from bovine eyes (135). Addition of specific antioxidants proved that LF-induced lipid photoperoxidation can be initiated by singlet oxygen (135). Moreover, LF photoinduced in vitro peroxidation of bovine serum albumin at pH 7.0 (105,135).

The effect on enzyme activity  ROS photoproduced in human RPE cells by LF caused dramatic drop of antioxidant potential expressed in significant inactivation of catalase (135,136) and superoxide dismutase and decline of intracellular glutathione level (136). The age pigment reduces activity of acid phosphatase both in the dark and when exposed to light (400–1100 nm) (135) and causes significant activity decrease of other lysosome enzymes (136). In addition, LF can stimulate photoreduction of cytochrome c under aerobic conditions (131).

Blue light hazard  Overall, the studies of spectral dependence within visible spectrum of RPE lipofuscin phototoxicity showed that the age pigment granules or material extracted from LF produce ROS most efficiently when they are exposed to blue light (120). It could explain “blue light hazard” to the retina (39,120). The RPE cells loaded in vitro with lipofuscin and exposed to blue-green light (400–550 nm) exhibited significant changes in morphology associated with lipid peroxidation, protein oxidation, loss of lysosomal integrity (94,114,123), increased cytoplasmic vacuolization, cell membrane blebbing, which led to significant decrease of cell viability (114,136) and even death (137). However, the “amber” light (550–800 nm) showed no negative effect on the cells, suggesting that lipofuscin phototoxicity is light-wavelength-dependent at least in vitro (137).

Age effect on LF photoreactivity  Lipofuscin photoreactivity is age-related (105). The age pigment granules isolated from RPE cells of older persons photoinduced oxygen uptake and formation of superoxide-derived spin adducts much faster than those from young individuals.

All-trans-Retinal

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

Visual cycle and lipofuscin formation

Retinoids—retinol, retinaldehyde (retinal) and retinyl esters—are vitamin A metabolites that are major constituents in the vertebrate visual cycle (138–141). 11-cis-retinal is reversibly bound to opsin—a protein present in the outer segments of rods and cones in the vertebrate eyes. Both the retinoid and the protein form a visual chromophore—rhodopsin. Light that reaches the retina induces photoisomerization of 11-cis-retinal to all-trans-retinal (atRal) (48,138,141–143). Most of atRal is released from rhodopsin into the disk lumen (142). The retinoid is transported from the inside of disk membranes into the cytoplasm (142,144) by the photoreceptor-specific ATP-binding cassette transporter (ABCA4/ABCR) (142,145,146) localized in the rim of the photoreceptor disk (147). There, all-trans-retinal is reduced to the less reactive all-trans-retinol (atRol) by NADPH-dependent all-trans-retinol dehydrogenases (RDHs), such as RDH8, RDH11 and RDH12 (48,139–142,144,148). Photoreceptors are unable to convert all-trans-retinal or all-trans-retinol back to 11-cis-retinal (25). Thus, all-trans-retinol is transported to the retinal pigment epithelial cells, esterified by lecithin-retinol acyltransferase, recycled to 11-cis-retinal and translocated back to the photoreceptors (58,149).

Not all atRal molecules formed in the POS are reduced to all-trans-retinol. All-trans-retinal in its free form is a highly reactive molecule. When it is released from photoactivated rhodopsin it can react with phosphatidylethanolamine (PE), a primary amine that is present in membranes of the POS at relatively high abundance, accumulate there and undergo condensation processes before the product reaches RPE cells during phagocytosis. It was shown that the concentration of all-trans-retinal released from opsin in vivo is relatively high and can reach the level of 3 mm (48,142). In addition, it was postulated that all-trans-retinal can be present in phagocytosed outer segment disks in the RPE cells after intensive illumination of the retina, when substantial amounts of atRal are rapidly generated (35,150) (Table 1). On the basis of studies performed on Rdh8−/−Abca4−/− mice, Maeda et al. (142) suggested that loss of the all-trans-RDHs, RDH8 and RDH12 enzymes, which facilitate conversion of all-trans-retinal to all-trans-retinol, can cause excessive atRal accumulation in the photoreceptors and its diffusion into the RPE cells. Yang and Fong (151) implied that all-trans-retinal can be synthesized directly inside the RPE cells. The oxidative cleavage of β,β-carotene catalyzed by β,β-carotene-15,15′-dioxygenase leads to atRal formation under dark or photic conditions directly in the RPE (151). Strauss (25) suggested that atRal synthesis is possible from all-trans-retinol of the retinylester pool in the RPE cells. It was shown that all-trans-retinol is oxidized efficiently by a specific retinol dehydrogenase and significant amounts of all-trans-retinal accumulate in ARPE-hRGR and bovine RPE cells in the absence of light (151). All-trans-retinal present in the RPE cells can be a substrate of retinal G protein-coupled receptor (RGR), a microsomal opsin detected in the cells (151).

Retinal plays an important role in lipofuscin formation in the RPE cells. The deficiency of all-trans-retinal and 11-cis isomer in Rpe65 knockout mice correlate with reduced accumulation of lipofuscin in the animal retina (152). Although Tolleson et al. (153) postulated ocular lipofuscin granules contain all-trans-retinal, but it is mostly stored in a dimer form (atRal dimer) and other condensation product such as A2E (142).

Dark cytotoxicity

RPE cells in vitro  All-trans-retinal causes distinct cytotoxicity in RPE cells in vitro (154). It stalls human RPE cell metabolism and makes cell membrane almost totally permeable after 24-h of incubation with 40 μm atRal or as soon as 3 h at 60 μm concentration. Similar cytotoxic effects of all-trans-retinal on cell metabolism were observed when ARPE-19 cells were incubated in the dark with atRal in its free form (49,58).

Mitochondria  Another study performed on isolated mitochondria determined that retinal as a product of β-carotene cleavage inhibited oxidative phosphorylation by 12% in isolated mitochondria at concentrations as low as 1 μm (155). In addition, all-trans-retinal inhibited mitochondrial oxidation and uncoupled oxidative phosphorylation at concentrations >50 μm in mitochondria isolated from rat hearts (58).

Cell membrane  All-trans-retinal in its free form has a high affinity with biological membranes, including cytoplasmic membrane, and may alter their stability (58). It can react via a Schiff base linkage with primary amines (49) present in membrane phospholipids and proteins. Binding of all-trans-retinal to the amine residues in membrane proteins can modify the structure of the cellular membrane and make it more permeable.

Lipid peroxidation  Modification of cell membrane structure can be associated with lipid peroxidation. We observed increased level of lipid hydroperoxides in the human RPE cells treated in the dark with 50 μm atRal (154). The formation of malonic dialdehyde, a product of lipid peroxidation, was also detected in mitochondria incubated with β-carotene cleavage products containing retinal (155). The thiobarbituric acid reactive substances (TBARS) assay showed a direct effect of all-trans-retinal on lipid peroxidation in ARPE-19 cells (147).

Antioxidants  All-trans-retinal can also affect antioxidant system in the RPE cells. Interaction of atRal with antioxidant enzymes can cause their deactivation, which could be associated with enhanced superoxide formation, increase level of hydrogen peroxide and induction of lipid peroxidation. The effect of all-trans-retinal on H2O2 formation in the dark was indirectly proven by noting the reduction in dark toxicity in the presence of catalase added to RPE cells preincubated with atRal (156). In our studies (154), we have shown that atRal modifies glutathione level in the RPE cells in vitro. The retinal at concentration of 25 μm slightly decreases intracellular level of glutathione reduced form (GSH) and enhances oxidation of the tripeptide after 5 h incubation. In addition, atRal induces parallel changes of cell membrane structure, which lead to significant glutathione leaking from the cells (154). Similar effects were observed in other studies, where β-carotene cleavage products containing retinal induced depletion of glutathione and protein-SH in isolated mitochondria (155). The level of GSH dramatically decreased in mitochondria in the presence of retinal and other cleavage products and a parallel increase in oxidized form of glutathione (GSSG) content was observed.

Photochemistry

Photochemical reactions of retinoids proceed through several possible routes—photoisomerization, photodegradation, photooxidation and photopolymerization (153,157).

Photoisomerization  Retinoids including all-trans-retinol and all-trans-retinal undergo isomerization into a mixture of trans- and cis-isomers (153) (Table 3). 13-cis and 9-cis-retinal were identified as the major photoproducts of atRal illumination with UV laser radiation in deoxygenated acetonitrile (157,158).

Table 3.   Photoisomerization, photodegradation and oxidation products of ocular retinoids.
ChromophorePhotoisomerizationPhotodegradationPhotooxidationReferences
ProductIllumination wavelengthSolvent
  1. CDCl3, deuterated chloroform; CHCl3, chloroform; deox., deoxygenated; MeCN, acetonitrile; MeOH, methanol.

all-trans-retinal13-cis-retinal 9-cis-retinal (UV, deox. MeCN)    (157,158)
 9,10-dihydroretinal   (56,158)
  all trans-5,8-peroxy-retinal MeCN(157)
A2E9-cis-A2E 13-cis-A2E (room light)    (57,168,172,173)
  A2E polyepoxides430 nm (199)
  A2E nonaoxiranes  (198)
  A2E monoepoxides>400 nmPBS(200)
  A2E epoxides MeOH(198)
  A2E 5,8-furanoid oxide  (201)
  A2E 5,8,5′,8′-bis-furanoid oxide  (201)
  Monoperoxy-A2E  (202)
  Bisperoxy-A2E  (202)
  Aldehydes and ketones formed after oxidized A2E cleavage  (216,217)
HIDD Bleaches in deox MeCN and MeOH   (206)
HIDD-H+ Bleaches in deox MeCN and MeOH   (206)
A1E  Pyridinum terpenoid425 nmMeOH(207)
  A1E cyclic 5,8-peroxide425 nmCDCl3(207)
atRal dimer (AD)  Oxygen adduct to AD double bond430 nmH2O, CHCl3(209)
AD-PE  Oxygen adduct to AD-PE double bond430 nmH2O, CHCl3(209–211)

Photodegradation  The all-trans-retinal absorption spectrum consists of a broad band in the range 280–480 nm with a maximal absorbance at 382 nm (Table 1). However, continuous irradiation of atRal in argon-saturated methanol caused almost total bleaching of the chromophore and formation of 9,10-dihydroretinal (Table 3), which has an absorption spectrum shifted to below 300 nm (56,158). Although fluorescence emission intensity of free atRal (λmax = 467 nm) is relatively low, it is getting diminished during long UV irradiation (158) (Table 1).

Photooxidation  When retinoids are exposed to UV light in air-saturated solutions they oxidize, giving products, such as retinol, 5,6-epoxide- and 4-keto-retinol and 5,6-endoperoxide (153). All-trans-retinal is photochemically less stable than ocular lipofuscin extract. In benzene, atRal bleaches much faster than ocular age pigment when exposed to UV light (60). All-trans-5,8-peroxyretinal was detected in irradiated atRal solution in acetonitrile (157) (Table 3).

Free radical photoformation  In vitro studies showed that all-trans-retinal exposed to UV or visible light (300–407 nm) produced free radicals in the presence of hydrogen atom or electron donors (56,57,153,159,160). EPR spin trapping experiments revealed that all-trans-retinal in deoxygenated methanol irradiated with UV and visible light (>300 nm) was able to abstract hydrogen atom from the solvent and generate its carbon-centered radicals (159) (Table 2). However, the retinyl spin adduct with 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was not detected. Similar effects of hydrogen transfer were observed when other retinoids were tested—retinol in methanol and retinyl palmitate (RP) in dimethylformamide (159), but free radicals were not detected in retinoic acid (RA) solution in methanol (159). However, Tolleson et al. (153) have shown that retinol in 70% ethanol exposed to UV produces carbon-centered radicals. Pulse radiolysis experiments performed by Różanowska et al. (160) revealed that atRal cation radical can be formed as a result of interaction with hydroxyl radical.

UV and light-induced production of superoxide anion  All-trans-retinal is an efficient photosensitizer and generates ROS in aerated solutions (57,153,159,160). When exposed to visible light (<418 nm) atRal Schiff base is able to transfer an electron from an electron donor such as reduced form of nicotinamide adenine dinucleotide to an oxygen molecule and form superoxide anion (159). Pawlak et al. (57) observed characteristic superoxide anion spin adducts to DMPO in dimethyl sulfoxide (DMSO)-benzene mixture (9:1) during exposure to visible light (407 nm) (Table 2). The reactive oxygen form can be also generated after atRal radical anion with molecular oxygen (160). However, atRal at its non excited form does not interact with superoxide anion (160).

Singlet oxygen photoproduction  Compared with other retinoids—atRol, retinoic acid and retinyl palmitate, all-trans-retinal most efficiently forms an excited triplet state (56) with lifetime at 9.3 μs (60). All-trans-retinal is the most effective visual cycle component that photogenerates singlet oxygen in vitro (57,60,159) (Table 2). The quantum yields of 1O2 photogeneration by atRal in methanol was determined as 0.05 and it was three and at least five times higher than in atRol and RP methanol solutions, respectively (159). Measurements performed in carbon tetrachloride revealed that the 1O2 quantum yield for atRal can reach the level of 0.25 (159). The efficiency of atRal in 1O2 photoformation is comparable to the human ocular lipofuscin organic solvent extract when solubilized in methanol (129). However, it was determined that the quantum yield in benzene for atRal is two to three times higher than for LF extract when irradiated with UV (355 nm) and even two to six higher during blue light (420–440 nm) exposure (60). Contrary to LF extracts, the quantum yield of singlet oxygen photoinduced formation by atRal remains generally stable for 355 and 420 nm of excitation wavelength and is oxygen concentration independent in the range of 1.9–9.0 mm O2 (60). In vitro studies performed by Pawlak et al. (57) have shown that oxygen uptake in all-trans-retinal samples was used mostly for 1O2 photogeneration, which was confirmed by the formation of 5a-hydroperoxycholesterol, a specific indicator of Type-II photosensitized oxidation of cholesterol.

Photobiology

All-trans-retinal-mediated photodamage to lipids and proteins is oxygen-dependent (147,161,162). The semioxidized retinoid can further interact with tyrosine and cysteine, leading to protein oxidation (160).

Light-induced photoreceptor damage  All-trans-retinal or other retinoid chromophores can play an important role in light-induced damage of photoreceptors and RPE cells (147), whereas atRol and RP were shown to be efficient antioxidants protecting POS lipids in vitro from peroxidation (16,86). Other in vitro studies have shown that all-trans-retinal exposed to visible light impairs the ABCA4 transporter present in POS (161). In addition, all-trans-retinal can cause photodamage to interphotoreceptor retinoid-binding protein (IRBP), which sustains photoreceptors and is responsible for retinoid transport between them and the RPE cells (163). All-trans-retinal bound to IRBP and exposed to visible light caused tryptophan fluorescence decay and thiol group oxidation in the protein structure as well as reduction of retinol binding activity. All-trans-retinal produced from 9-cis-retinal in 661 W photoreceptor cells induced their apoptosis after illumination with visible light (453 nm) (164). Interestingly, the same in vitro study has shown that all-trans-retinol is not toxic to the photoreceptor cells under the same experimental conditions (164). Lipids in ARPE-19 cells preloaded with atRal underwent faster peroxidation when the cells were exposed to UVA and TBARS concentration rose during irradiation (147). In vivo, atRal can induce light-dependent degeneration in the retina of rpe65−/− mice (147). The absence of 11-cis-retinal and all-trans-retinal in the photoreceptors made the mouse retina resistant to light toxicity. Maeda et al. (142) in their studies observed acute form of retinopathy in light exposed mice that lack two enzymes—ABCA4 and RDH8, which are responsible for atRal clearing. The toxic effects were characterized by increased cell membrane permeability and mitochondria-derived apoptosis. Interestingly, the authors emphasized that excess accumulation of atRal, but not A2E or other product of retionoid condensation was the main reason of the observed light-induced retinopathy.

Phototoxicity in the RPE  Our studies have shown that human RPE cells partially impaired by the dark cytotoxic effect of all-trans-retinal (<30 μm) and then irradiated with visible light (>400 nm) were exposed to additional stress in the form of reactive intermediates of retinal and oxygen (154). Short light exposure caused further decline in cell metabolism and enhanced cell membrane permeability. A phototoxic effect of all-trans-retinal was also observed when ARPE-19 cells were preincubated with a higher (0.1 mm) retinal concentration in phosphatidylcholine liposomes and exposed to visible light (156). In addition, irradiation with blue light (440 nm) caused photodamage in the same type of RPE cells and also in HEK293 cells derived from human kidneys as well at much lower concentrations of free all-trans-retinal (58). However, light effect of RPE cells pretreated with atRal is not unambiguous. In our studies, light (>400 nm) exposure of RPE cells fed with atRal (<50 μm) modified the level of intra- and extracellular glutathione and affected lipid peroxidation and formation of other hydroperoxides, but these effects depended on atRal concentration and time of light exposure (154). Prolonged irradiation induces bleaching, isomerization and autooxidation of the retinal, which in effect lead to decrease in formation of retinal-derived photoreactive products and ROS. The presence of antioxidants and phospholipids containing amine groups in the cell membrane counteract the negative effects of oxidative stress caused by enhanced level of atRal in its free form. Różanowski et al. (156) showed in their in vitro studies that phototoxicity of all-trans-retinal toward RPE cells is significantly reduced by α-tocopherol and zeaxanthin. In addition, atRal toxicity was significantly inhibited in the ARPE-19 cells that were treated with liposomes containing the retinoid and phosphatidylethanolamine (156). Moreover, the semioxidized atRal-PE adducts are less damaging to proteins than semioxidized atRal (160).

A2E

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

The lipofuscin chromophore

Spectroscopic analyses have revealed that the lipofuscin present in the human RPE contains numerous chromophores (92,120,126,129). At least a dozen of them have been isolated and characterized.

A2E {chemical name: 2-[2,6-dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E,7E-octatetraenyl]-1-(2-hydroxyethyl)-4-[4-methyl-6-(2,6,6-trimethyl-1-cyclohexen-1-yl)-1E,3E,5E-hexatrienyl]-pyridinium} (165), also called N-retinylidene-N-retinylethanolamine (166) is a major and the first isolated fluorophore from RPE lipofuscin (102,167). It occurs in the RPE cells mostly in 2 isomeric forms all-trans-A2E and 13-cis isomer (iso-A2E) (168,169). It is estimated that iso-A2E constitutes 15–20% of entire pool of A2E in the human ocular lipofuscin (61,169).

A2E biosynthesis and accumulation in age

Biosynthesis  All-trans-retinal in its free form is a highly reactive molecule. After release from photoactivated rhodopsin in POS, all-trans-retinal can bind to phosphatidylethanolamine (92,102,146,166,170), a primary amine that is present in POS membranes of at relatively high abundance (ca 40% of total phospholipids) (146,170). A fraction of the all-trans-retinal-PE Schiff base (N-retinylidene-PE; APE) can undergo further condensation (166,170,171). Another atRal molecule can bind to APE to produce dihydro-N-retinylidene-N-retinyl phosphatidylethanolamine (A2PE-H2), which is transported during POS phagocytosis to the RPE cells (166). After oxidation and cyclization, A2PE-H2 is transformed to N-retinylidene-N-retinyl phosphatidylethanolamine (A2PE) (166). The phosphate ester is hydrolyzed in phagolysosomes (166) more likely via enzymatic reaction (170–172) to yield A2E chromophore (103,166,170), inside the retinal pigment epithelial cells (20,166,170,173–175). However, Ben-Shabat et al. (172) observed that A2PE can be at least partially synthesized inside POS before internalization by RPE cells. In addition, they suggested that some amounts of A2PE could be converted into A2E inside non phagocytosed POS (172).

Accumulation in the RPE  The bis-retinoid together with other fluorescent chromophores accumulates with age in lipofuscin granules (102). Studies performed by Delori et al. (103) have shown that lipofuscin fluorescence increases lineary with age until 70 years. It implies that A2E could accumulate in the age pigment granules at the same rate. Indeed, the measurements of A2E level conducted by Bhosale et al. (176), on the human eyes from donors at age 20–88 y.o. have shown that A2E builds up in the RPE mostly in the linear manner. The constant accumulation of A2E in RPE cells in vitro and the saturation of that process observed by Schutt et al. (175) suggest that RPE cells do not possess a mechanism that could lead to A2E degradation. However, the recent studies of Wu et al. (177) have shown that A2E loaded in vitro to the RPE cells can be cleaved by horseradish peroxidase.

The A2E level and spatial distribution in the retina

A2E level in the human eye  The A2E amount in the human RPE cells in vivo can reach level of 60–130 ng 10−5 cells (169) or 830 pmol per eye (168), which is comparable to the bis-retinoid level in the RPE cells incubated in vitro for several hours with 15–30 μm A2E (169,174,178). Davies et al. (137) estimated that the age pigment isolated from the human eyes contains both isomeric forms of A2E on average: 7.8 10−20 mole/LF granule or 2.4 10−17 mole/RPE cell. Most recently, Bhosale et al. (176) determined A2E and iso-A2E amount in the human RPE/choroid in two age groups. An average level of A2E and its isomeric form in donors younger than 50 y.o. was 6.4 and 0.6 ng per eye, respectively. Persons older than 50 y.o. had significantly higher level of both A2E forms—11.8 and 2.2 ng per eye, respectively.

A2E levels in Stargardt’s disease  Increased accumulation of A2E in young age is observed in persons suffering for Stargardt’s macular degeneration—genetically caused malfunction of the rod photoreceptor-specific ATP-binding cassette transporter responsible for flipping atRal-PE Schiff base adduct from the intradiscal to the cytosolic face of POS disk membrane what facilitates reduction of atRal by atRol dehydrogenase and constrains accumulation of A2E (146,166,170,171,179).

A2E in animals’ eyes  A2E accumulates also in other mammals, such as monkeys, cow, pigs, rats and mice (20,33,102,176). For example, Sutter et al. (20) determined 4 and 42 pmol A2E per eye in rats weighing 200 and 350 g, respectively. However, A2E in albino Sprague–Dawley rats (3-month old, male) was detected in the retina at the level of 6 pmol μmol−1 fatty acids (33).

Spatial distribution  Similarly to lipofuscin autofluorescence, A2E distribution in the human RPE is not uniform (103). The level of A2E in the macula is on average ca four times lower compared to the periphery of the retina in persons younger than 50 y.o. (176). With age, the bis-retinoid amount increases faster in the macula than in the periphery. The macula/periphery ratio of A2E level in the group of donors older than 50 y.o. drops to 3.4. Similarly to the human eye, A2E shows diversified spatial distribution in the mouse eyes (Fig. 4B). Grey et al. (180) have recently reported that A2E was detected mostly in the central RPE region of the eyes in 2-month old mice. However, with age A2E accumulated also across the tissue. A good correlation between A2E and lipofuscin distribution has been also observed.

Interestingly, A2E distribution in the human RPE/choroid seems to be inversely correlated with the concentration diversity of the retinal carotenoids. The level of carotenoids in the macula is 3.5–4.0 times higher than in peripherial region of the human retina (176).

A2E distribution inside RPE cells  It has been shown that A2E accumulates in the RPE cells in vitro in the perinuclear region (169,181) being delivered mostly (ca 90%) to lysosomes (102,169,175,182). In addition, the bis-retinoid can accumulate to a lesser extent in mitochondria, Golgi apparatus and the cytoplasm membrane (175).

Illumination effect  Light exposure affects A2E biosynthesis. Studies using the Abca4−/− transgenic mouse model for Stargardt’s macular degeneration have shown that the biosynthesis of A2E greatly accelerated when the animals were housed in a cyclic light/dark mode when compared with those stored in complete dark (166,183). Different intensity of ambient light seems not to affect A2E level in RPE cells of the transgenic mice, both albino and pigmented (184).

Dark cytotoxicity

A2E structure and chemical properties  A2E is generally less reactive than its precursor all-trans-retinal. The engagement of atRal formyl group in reaction with the amine group of phosphatidylamine during condensation reaction makes A2E less reactive than its precursor toward nucleophilic groups, such as amines in proteins. However, A2E is a quaternary amine with molecules of pyramidal shape (178) with two hydrophobic retinoid chains. Its structure predestinates A2E to act as an amphiphilic detergent, which is able to modify phospholipid membrane arrangement (102,169,178).

Cell metabolism and membrane integration  A2E presence in the RPE cells can affect their metabolism through several mechanisms. The fluorophore inhibits the growth of human RPE cells in vitro at concentration as low as 1 μm (185). A2E at concentration of 25 μm that is comparable to its level in human ocular lipofuscin does not impair human RPE cell metabolism tested with MTS assay (154). The intracellular level of glutathione was not affected in the cells treated with 12.5 μm A2E. However, twice higher concentration of A2E caused the intracellular level of oxidized glutathione form to be raised three-fold, but the total concentration of both tripeptide forms was unchanged (154). In addition, 25 μm A2E did not increase lipid hydroperoxide level in the RPE cells, did not enhance cytoplasm membrane permeability detected as lactate dehydrogenase (LDH) release from the RPE cells in vitro and did not induce significant glutathione efflux from the cells (154). However, Sparrow et al. (169) studies have shown that although A2E was not detected in the cytoplasm membrane, the elevated level of LDH release was observed in the RPE cells exposed to much higher concentrations (50–100 μm) of the bis-retinoid. In addition, A2E at the level of 50 μm impaired phagocytotic properties of the RPE cells in vitro (186).

Mitochondria  A2E toxicity toward RPE mitochondria seems to be ambiguous. Several studies have shown that the bis-retinoid at <5 μm impaired function of isolated cytochrome oxidase (187), and at 30–45 μm A2E inhibited activity of the enzyme in mitochondria isolated from rat liver (20). A2E at concentration of 50 μm diminished mitochondrial ATP synthesis in human RPE-J cells (186). However, the lipofuscin fluorophore did not affect the respiratory chain activity upstream of cytochrome c (20). On the other hand, studies performed by Maeda et al. (58) revealed that while all-trans-retinal inhibited mitochondrial oxidation and uncoupled oxidative phosphorylation at concentrations >50 μm in mitochondria isolated from rat hearts, A2E did not affect these metabolic functions even at a concentration of 600 μm.

Lysosomes  The inhibition of the ATP-driven proton pump of lysosomes was observed in the RPE cells incubated with only 2 μm A2E (188). Although Holz et al. (182) initially suggested that A2E inhibited lysosomal digestion of proteins, Finnemann et al. (189) showed that lysosomal proteolysis is unaffected directly by A2E. In the same study, they presented significant inhibition of phagolysosomal degradation of photoreceptor phospholipids in the cells treated with 100 μm A2E (189). Further experiments of that group (178) revealed more details on A2E effect on lysosome activity and cholesterol metabolism and in the RPE cells. A2E as a quaternary amine, in contrast to classical lysosomotropic amines, does not increase pH in late endosomes and lysosomes and does not inhibit directly the activity of several lysosomal enzymes in the RPE cells (treated with 15 μm A2E for 6 h) in vitro. However, as it was demonstrated using liposomes as a model of a phospholipid bilayer, the bis-retinoid competes with cholesterol for a place in the membrane. Thus, during the digestion process of POS phagocytosed by RPE cells A2E present in the photoreceptor material accumulates in the endosome membrane and restricts cholesterol efflux from the late endosomes. Increased level of cholesterol in late endosomes and lysosomes induces inhibition of acid lipase and leads to buildup of cholesteryl esters and oxidized cholesterol in the cells.

Apoptosis  A2E can induce cell apoptosis in the dark. Suter et al. (20) have shown that 25–50 μm A2E treatment of the porcine RPE cells for 24 h induced internucleosomal fragmentation of genomic DNA and positive TUNEL staining. However, apoptosis can be induced by the bis-retinoid in neurons at lower concentrations. A2E at concentration of 20 μm triggered detachment of cytochrome c from the mitochondria and release of apoptosis-inducing factor after 20 h treatment of cerebellar granule cells isolated from 8-day-old BALB/c mice and then cultured in vitro (20).

Cytotoxicity of A2E and its precursors  Despite the fact that A2E shows limited reactivity, a comparison of the cytotoxicity of A2E and all-trans-retinal leads to the general conclusion that condensation of atRal into A2E protects RPE cells from cytotoxic effect of increased levels of the retinal in phagocytosed POS (154,174). In vitro studies performed on ARPE-19 cells showed that atRal toxicity was significantly inhibited when phosphatidylethanolamine was present in liposomes containing the chromophore (156). The semioxidized atRal-PE adducts are also less damaging to proteins than semioxidized atRal (160).

Thus, it seems that the buildup of undigested material in the RPE and/or the destruction of the postmitotic cells could contribute to the development of AMD and progression to its severe atrophic form.

Spectrophotometric properties

Light absorption  The absorption spectrum of all-trans-retinal, an A2E precursor is located mostly in UV, characterized by one band with a maximum at 380 nm. The retinal absorbs only slightly in the visible light range up to 450 nm (56) (Table 1). However, the condensation of 2 atRal molecules into A2E form causes that the bis-retinoid, contrary to its precursor absorbs efficiently the short-wavelength light of the visible range. A2E absorption spectrum is characterized by two maxima at 336 and 430–439 nm (168,173,190) and at 550 nm its absorbance decreases to 5–10% of the long-wavelength peak (103).

Fluorescence  The fluorescence of lipofuscin in the RPE cells was of interest to scientists investigating photobiological properties of the age pigment. The characterization attempt of the major chromophore responsible for the LF fluorescence led to extraction and isolation of A2E (102). Intensity and the maximum of fluorescence emission spectrum depend on the environment in which A2E is present and the excitation wavelength (Table 1). In organic solvents, the fluorescence emission was detected at 585–610 nm (169) and 510–570 nm (173), when A2E samples were irradiated with 380 and 430 nm, respectively. The maximal intensity of fluorescence emission of A2E in Triton X-100 micelles illuminated at 430 nm was registered at 615 nm (173). The emission maxima of A2E incorporated in liposomes or RPE cells have been observed in the range of 550–590 nm (191) and 565–570 nm (169) when excited at 400 and 380 nm, respectively.

In vitro studies performed on synthetic A2E in ethanol showed that most of its photoexcited molecules return to the ground state via non radioactive emission (57,190). Although the quantum yield of A2E fluorescence detected in the micelles (173) or in the RPE cells in vitro (185) was 1.5–5 times higher than in pure solutions, the energy of light absorbed by the bis-retinoid is only partially (ca 1%) emitted back as fluorescence (101,173,190). More detailed studies have revealed that the presence of relatively intensive autofluorescence observed in the human retina when excited at 550 nm (103) suggests that A2E is not the main fluorophore responsible for long-wavelength fluorescence emission from LF granules. Nevertheless, A2E can serve as an energy acceptor from other blue light absorbing molecules present in lipofuscin (101,173,192).

Photoreactivity

Absorption of light mostly in the blue light range and golden fluorescence similar to lipofuscin (101) implied that A2E could be a good candidate for the most potent photosensitizer of the ocular lipofuscin (49).

Photoisomerization  A part of the energy of light absorbed by A2E can be used for conversion of A2E molecule into its 13-cis isomer (iso-A2E) (57,168,173) (Table 3). It is likely that the photoequilibrium between these two forms of A2E occurs also in vivo (169). Other isomeric forms of A2E (9-cis, 11-cis) have been also detected as products of A2E photoisomerization in room light (172).

Photogeneration of the transient intermediates  Reszka et al. (130) showed that irradiation of the products of reaction typically used for A2E formation in vitro between atRal and ethanolamine (2:1) then fractionated with HPLC led to generation of transient species (the triplet state and a free radical insensitive to oxygen), which characteristics were similar to LF extracted from human RPE cells. However, the carbon-centered radicals detected during the studies were slightly different than those obtained in extracts from natural human lipofuscin.

Only a small portion of the energy absorbed by A2E is used to produce its transient reactive forms. The bis-retinoid is characterized by inefficient intersystem crossing (57,173,190,192). In vitro research revealed that pure A2E does not efficiently produce a long-lived triplet excited state, an intermediate that is essential for generation of singlet oxygen or other ROS (173,190,192). The quantum yield of that process was estimated to be below 0.01 after A2E excitation at 355 nm in methanol and benzene (192) and at most 0.03 in methanol solution of the bis-retinoid illuminated at 430 nm (190).

A2E and other blue-light photosensitizers  The low quantum yield of transient species formation of A2E and its photophysical properties in association with its concentration in lipofuscin granules strongly suggest that this fluorophore is not responsible for LF phototoxicity (57,61,137,190,192). It was estimated that A2E-derived phototoxicity in cells loaded with the ocular age pigment was responsible for maximum 1% of total lipofuscin photodamaging potential (137). Generally, A2E possesses far less-photosensitizing properties than lipofuscin (60,61), all-trans-retinal (57,58,154), protoporphyrin (193), or other endogenous blue light chromophores in the RPE (194). For example, Pawlak et al. (57) using EPR oximetry determined that liposomes containing 150 μm A2E illuminated with light at wavelength of 407 nm consumed oxygen 20.6-fold slower than did those containing 390 μm all-trans-retinal. The comparison of the rates of oxygen photouptake by A2E and ocular lipofuscin suspended in liposomes determined that the bis-retinoid consumed oxygen ca 100 times slower than lipofuscin, when normalized to A2E content in the human ocular age pigment (61).

Superoxide anion photoproduction  In vitro studies proved that A2E shows insignificant photoreactivity and is generally much less efficient at producing ROS compared with other blue light chromophores in the aged retina (57,61,173,174,195) (Table 2). EPR spin trapping performed by Reszka et al. (130) have shown that the products of A2E synthesis can photogenerate superoxide anion. The results of further experiments carried out in vitro using EPR spin trapping (57,61,196) and pulse radiolysis (197) proved that A2E is able to produce superoxide anion. Pawlak et al. (57) have shown that A2E illuminated with 407 nm light in DMSO/benzene (9:1) mixture produced superoxide anion 3.2 times slower than lipofuscin extract, but ca four times faster than all-trans-retinal, all normalized to the same absorbance at 403 nm. The quantum efficiency for O2˙ generation by A2E determined in that study was very low (0.0003), when riboflavin (RF) was used as the model of superoxide anion generator (ΦRF = 0.01).

Light-induced singlet oxygen formation  A2E can also photogenerate singlet oxygen, but the quantum yield of that process is not higher than 2% (57,173,192) (Table 2). When detection of 1O2 characteristic phosphorescence at 1270 nm was employed, 1O2 quantum yield has been estimated as 0.02 in acetonitrile (190) and 0.013 in deuterated cyclohexane/deuterated acetone (4:1) mixture (195) when exposed to UV (355 nm). Interestingly, it was determined at much lower level when A2E solutions were illuminated with blue light—0.004 in CCl4 at 435 nm (174) or hexafluorobenzene at 420 nm and even less in perdeuterated solvents (195). It is at least one order of magnitude lower than for all-trans-retinal (Φ = 0.24–0.25 in CCl4)—the precursor in A2E biosynthesis (159,174). Pawlak et al. (57) and Kanofsky et al. (195) showed even larger differences in quantum yield of 1O2 photoproduction by A2E and its precursor when measured specific products of cholesterol peroxidation. A vestigial concentration of 5α-cholesterol hydroperoxide—the specific 1O2-derived peroxidation product detected in A2E samples indicated that the rate of singlet oxygen formation during illumination of A2E at 412–500 nm is ca 70 lower than in samples containing atRal, when normalized to the same absorbance of both chromophores at 403 nm (57). Although irradiation of A2E also releases ROS, the quantum yield is insufficient to account for the amount of ROS produced by lipofuscin.

Antioxidant properties  A2E is a relatively efficient quencher of singlet oxygen, with a quenching rate of ca 3 107 m−1 s−1 in CCl4 (198) and 2 108 m−1 s−1 in acetonitrile (174), which is comparable to vitamin E or ascorbic acid (174).

A2E photooxidation  A2E is a reactive molecule can be easily oxidized, particularly when irradiated (184,194,198–202) (Table 3). Illumination of A2E in vitro in air-saturated solvents leads to the formation of A2E oxidation products (184,194,198–200). Gaillard et al. (196) have shown that A2E photoreactions in air-saturated solvents run faster in water vs chloroform and in hydrogenated vs perdeuterated methanol. It was implied that the solvent effect and the phenomenon that products of A2E photooxidation are characterized by sequential oxygen addition primarily through a free radical mechanism (196). Moreover, photooxidation mediated by 1O2 would lead to the addition of two oxygen atoms to A2E molecule (196). A2E is not a sole photosensitizer present in the RPE lipofuscin, which absorb blue light (61). There are other chromophores that are sufficiently phototoxic (59,60) that could oxidize A2E both via free radical and singlet oxygen mechanism.

The experiments performed on laboratory animals have proven that A2E photooxidation can take place in vivo. The studies on the Abca4−/− transgenic mouse have revealed that A2E conversion to oxidized form(s) is greatly accelerated by light (166,184). Intensive blue light illumination (450 nm) of Sprague–Dawley rats caused the total amount of A2E and its isomer (iso-A2E) in the retina (normalized to fatty acid content) to decrease six- and four-fold, respectively in comparison to animals housed in the dark (33). Blue-light (450 nm) exposure promoted oxidation of A2E and iso-A2E and accumulation of A2E oxidative products (33,184) that could be toxic to retinal tissue.

Photobiology

A2E is the major fluorescent components of lipofuscin. The question has been raised whether A2E is the primary photooxidizing agent for blue light damage to the retina. Numerous studies have shown that A2E can be at least partially responsible for lipofuscin phototoxicity in the RPE cells.

Photobiological activity  A2E present in lysosomes of the RPE cells treated in vitro with bis-retinoid-LDL complex and exposed to blue light (390–550 nm) caused disruption of lysosomal membranes (203). Cytochrome oxidase inhibition was observed in mitochondria isolated from rat liver, pretreated with 15 μm A2E and illuminated with a tungsten lamp (20). It has been reported that A2E (at the concentration of 50–100 μm) is the source of blue light-mediated (480 nm) ROS that can lead to RPE cell apoptosis (204,205).

On the other hand, A2E at the physiological level (<25 μm) did not affect metabolism (determined with MTS assay) and did not enhance cytoplasmic membrane permeability (measured as LDH release from the cells) in the human RPE exposed in vitro to visible light (λ > 400 nm) (154). Moreover, Roberts et al. (174) have shown that A2E protected the undifferentiated human RPE cells in vitro from UV-induced (>300 nm, 80 mJ cm−2) photodamage and breaks in DNA at the concentration of the fluorophore of 5 and 1–5 μm, respectively. However, the A2E protecting properties were not observed when the cells were illuminated with visible light (<400 nm) or the fluorophore concentration reached 10 μm.

Photobiological role of A2E in ocular lipofuscin  Photophysical and photochemical properties of A2E markedly differ from those of either LF granules or LF extracts (60) and from its biosynthesis precursor—all-trans-retinal (57,154,156,160). Photoreactivity of A2E is at least two orders of magnitude lower than lipofuscin when compared to the endogenous equivalent of the retinoid derivative in LF granules (120). Although A2E may be harmful at high concentrations, its cytotoxic and phototoxic effects even at the highest physiological level (20–25 μm) are much lower compared to the free form of its precursor all-trans-retinal at the same concentration or other LF components.

Retinal and A2E Derivatives

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

Since the time when A2E was described as the major fluorophore of ocular lipofuscin, many derivatives of the bis-retinoid have been identified in the retinas or theoretically proposed (102,166). One group is formed by the intermediates of A2E synthesis, the other is made up of additional all-trans-retinal condensation forms, whereas the products of A2E oxidation can be rated among the compounds forming the third group.

A2E synthesis intermediates

atRal-PE Schiff base  APE is an imine form of all-trans-retinal and phosphatidylethanolamine and is one the precursors of A2E (170). APE absorbs in the range of visible light similar to A2E, but is characterized by only single band with maximal absorbance in acetonitrile solution at 456 nm (170) (Table 1).

HIDD  Synthetic APE analogues—(E,E,E,E)-2-[9-(2-hydroxyethyl)imino-3,7-dimethyl-1,3,5,7-decatrien-1-yl]-1,3,3-trimethylcyclohexene (HIDD) and its protonated form HIDD-H+, which are the products of atRal reaction with ethanolamine (EA) have been described by Harper and Gaillard (206). HIDD absorbs mostly in UV with maximum at 360–370 nm in acetonitrile, whereas the main HIDD-H+ absorption is much redshifted with its peak at ca 450 nm (Table 1). Both HIDD forms are weakly fluorescent. The intensity of HIDD emission is stronger than HIDD-H+, with λmax in dichloromethane at ca 520 and 610 nm, respectively. Direct excitation can induce generation of HIDD triplet state; whereas the intermediate form of HIDD-H+ can be produced only via energy transfer from the triplet state of other photosensitizer. In addition, HIDD bleaches faster than HIDD-H+ both in deaerated acetonitrile and methanol, when exposed to irradiation at the wavelengths at their respective absorption maximum (Table 3).

A1E  A1E is another product of reaction between atRal and EA, which has a structure like A2E with only one retinoid arm (207). It seems that this product because of its molecular structure is not physiologically relevant. Its absorption spectrum is characterized by one intensive band with maximum at 417 nm in methanol (Table 1). It shows very week fluorescence with λmax at 560 nm. Illumination of A1E solution with blue light (425 nm) in air-saturated methanol and perdeuterated chloroform leads to formation of two different photoproducts—a pyridinum terpenoid (a product of cyclization; λabs max = 294 nm) and a cyclic 5,8-peroxide (λabs max = 363 nm), respectively (Table 3). Both photoproducts were detected when CHCl3 was used a solvent. The peroxide was also produced during A1E peroxidation with 1O2 generated by thermal decomposition of aromatic endoperoxide.

A2PE-H2  Condensation of APE with another atRal molecule leads to formation of dihydro-N-retinylidene-N-retinyl phosphatidylethanolamine (A2PE-H2). It was first observed in extracts from POS and RPE of Abca4−/− mice by Mata et al. (166). Significant accumulation of the bis-retinoid with age was observed in that type of mice, as well as in the human retina and RPE of persons with macular disorders (166,183). The absorption spectrum of the chromophore is characterized by two bands—one at 205 nm and the second band is considerably redshifted in comparison to the long-wavelength band of A2E, with a maximum at 500 nm (166) (Table 1).

A2PE  It has been demonstrated by Mata et al. (166) that A2PE-H2 in acidic environment can be oxidized to form N-retinylidene-N-retinyl phosphatidylethanolamine (A2PE)—the next intermediate in A2E biosynthesis. They detected A2PE, contrary to its precursors only in the RPE cells of mice (166,183). However, Liu et al. (170) observed A2PE both in the retina and the RPE isolated from rats. Fishkin et al. (208) identified a novel fluorophore—A2-Rh during incubation of excessive amount of atRal with isolated bovine rod outer segments (Table 1). A2-Rh is formed with 3 bis-retinoids (A2) bound to lysines in a rhodopsin molecule. Depending upon where exactly A2PE is generated, the pirydyl ring formation in the A2PE structure caused modification of the two-band absorption spectrum (Table 1). The maxima of A2PE extracted from 6 months Abca4−/− mouse RPE were detected at 330 and 430 nm (166). However, A2PE in acetonitrile solution prepared by Liu et al. (170) had maxima at 337 and 456 nm. Ben-Shabat et al. (171,172) demonstrated that A2PE emits orange fluorescence.

Additional products of all-trans-retinal condensation

All-trans-retinal dimer  Fishkin et al. (209) have demonstrated that two molecules of all-trans-retinal can form a dimer before reaction with PE and together produce another conjugate that could be present in the POS. The atRal dimer was found in bleached rod outer segments incubated with atRal. Absorption spectra of atRal dimer and its product of conjugation with PE (AD-PE) are characterized by two bands with maxima at 295 and 432 nm and 285 and 506 nm, respectively (Table 1). The dimer effectively oxidizes when exposed in air-saturated solution to blue light (430 nm), but the rate of photooxidation is higher in water than in chloroform (209) (Table 3). It has been suggested that the photooxidation products of atRal dimer are formed by addition of oxygen to double bonds and an aromatic demethylation can occur. Sparrow’s group has shown that atRal dimer (210,211), its oxidative products (212) and atRal dimer conjugates with PE (209–211) and ethanolamine (210) have been detected in Abca4−/− mouse eyes, bovine RPE and neutral retina and in human RPE/choroid. However, a study performed by Bui et al. (213) did not support the atRal dimer presence in Abca4−/−mouse eyes. Most recently, it has been demonstrated that atRal dimer can accumulate in relatively small amounts in the retina of Royal College of Surgeons (RCS) rats that possess impaired photoreceptors (214).

A2-DHP-PE  A2-dihydropyridine-phosphatidylethanolamine (A2-DHP-PE) is another atRal-related chromophore, similar to AD-PE and reported by Wu et al. (211). It is a fluorescent compound with two bands in absorption spectrum and maxima at 330 and ca 490 nm (Table 1). It has been detected in bovine and human RPE and in Abca4−/− mouse eyes, where age-related accumulation was observed.

A2-GPE  Most recently, a new fluorescent bis-retinoid compound has been identified (215). It is a product of the reaction between 2 atRal molecules and glycerophospho-ethanolamine (A2-GPE). Similarly to the previously described atRal condensation products, its absorption spectrum possesses two bands with maxima at 338 and 443 nm. It has been shown that the new fluorophore (λmax = 610 nm) accumulates with age in Abca4−/− mouse eyes (Table 1).

A2E oxidation products

A2E in solutions oxidizes relatively easily in the presence of oxygen. It appears that blue light (430 nm) exposure promotes the oxidation of A2E and its iso-forms in vitro (194). Comparatively, high-singlet oxygen quenching rate of A2E (174) implies that the bis-retinoid can be oxidized by that reactive oxygen form, mostly via photosensitization process.

Generation of A2E oxidation products  Ben-Shabat et al. (198) were the first to describe oxidation process of A2E induced by intensive blue light (430 nm) exposure in vitro. Using mass spectroscopy (MS), they observed A2E photooxidation products at mass to charge ratio (m/z) 608 and 624, with the molecular ion peak (M+) higher than the A2E peak by 16 and 32, respectively, suggesting that the A2E oxidation products are mono- and di-epoxides at carbon-carbon double bonds (194). The products were called oxiranes (198). Prolonged blue-light (430 nm) exposure produced polyepoxides (199) with even nine oxygen atoms bound to A2E molecule (nonaoxirans) (198). However, Avalle et al. (200) have shown that illumination of 6.5 μm A2E suspension in PBS with visible light (>400 nm) induced generation of a mono-oxygenated product of A2E only. A2E epoxides were generated also by A2E oxidation with an aromatic endoperoxide in methanol (198) or meta-chloroperoxybenzoic acid (184).

Oxidized A2E in biological material  Sparrow et al. (199) observed specific MS peaks at m/z 608, 624 and 640 in chloroform/methanol extracts from A2E-loaded RPE cells illuminated in vitro with blue light (430 nm). However, Avalle et al. (200) observed again the mono-oxygenated product of A2E as the only one generated in calf’s primary RPE cells treated three times with 10 μm A2E and illuminated for 3 h with a solar simulator.

The extracts from retinas and RPE cells of 7 m.o. Abca4−/− transgenic mice raised under intensive cyclic light contained significant amounts of A2E oxidation products (184). The MS spectrum were characterized by the family of ions, which m/z increased by 16 mass units from the A2E peak at 592 up to 736, what the study authors considered as A2E polyepoxides. Intensive blue light (450 nm) illumination in a short time led to accelerated accumulation of A2E oxidative products, which was accompanied with decrease in the bis-retinoid level (33). The concentration of the A2E oxidation products, which m/z was higher than A2E (m/z = 592) at 16, 32 and 48 increased significantly in the rats’ retinas and RPE.

Accumulation in age  A2E oxidized forms may also accumulate with age in the animal and human RPE. Avalle et al. (200) detected only mono-oxygenated A2E in human lipofuscin granules obtained from donors at age 66–80 y.o. Grey et al. (180) detected single-, double- and triple-oxidized forms in mouse retinas. Their level increased with age, but the ratio A2Eox/A2E remained constant for over 6 months. In the human eyes, A2E and iso-A2E were solely present in the RPE of persons younger than 50 y.o., moreover A2E oxidation products at m/z 608 and 624 were detected in the retinas of donors older than 50 y.o. without documented maculopathy at the level of 3% of total A2E (176).

The chemical structure of A2E oxidation products  Gaillard’s group initially considered the mono-oxygenated product of A2E as A2E mono-epoxide (200). Their more detailed studies let them conclude that the A2E oxidation products observed in mass spectroscopy measurements at m/z 608 and 624 were A2E actually 5,8-furanoid oxide and A2E 5,8,5′,8′-bis-furanoid oxide (201). In addition, they questioned the possibility of A2E poly-epoxide formation depending on environment, where they could be generated. Reinvestigated studies of Sparrow’s group have revealed more oxidative A2E products, including monoperoxy- and bisperoxy- forms (202). It was also suggested that highly reactive aldehydes and ketones can be formed after cleavage of oxidized A2E products (216,217).

Spectrophotmetric properties  The spectrophotometric characteristics of the mono- to tetra-oxygenated A2E products (200–202) revealed that they absorb in UV and the visible region below 550 nm (Table 1). They have two main bands in their absorption spectra with UV band maximum at 295–340 nm and the more intensive longer-wavelength one at 400–440 nm. Fluorescence measurements of A2E oxidation products showed that emission intensity of the oxidized forms is higher than the native bis-retinoid (212).

Cytotoxicity  Sparrow et al. (194) performed studies, which have revealed that the A2E photooxidation products considered by them as A2E epoxides cause lesions in nuclear DNA of RPE cells in vitro. Photooxidation of A2E in human ARPE-19 cells (treated with 10 μm A2E) with blue light (430 nm) resulted in formation of peroxy-A2E and furano-A2E, which induced complement component C3 activation, C3a formation (218) and also deposition of C3, factor B, H and membrane attack complex (MAC) (109).

Antioxidants—vitamin E and C reduce in vitro DNA damage (194) and together with anthocyanins protect the RPE cells from death (194,202) induced by the A2E oxidation products generated during blue light (430 nm) exposure.

Oxidized A2E precursors  The intermediates of A2E biosynthesis can also be a target for oxidation. Kim et al. (219) have shown that A2PE illumination with blue light (430 nm) in PBS leads to oxidation of the A2E precursor and generation of oxidative products similar to those obtained during A2E photooxidation.

Nevertheless, A2E present in the lipofuscin granules may not be photooxidizing itself. However, there are sufficient endogenous blue- or visible-light photoactive components in the ocular lipofuscin that may easily photooxidize A2E to its multioxidized products also in vivo (59,60,105,130,134,137,220–222). High concentrations of A2E may be cytotoxic to the retina and A2E itself has a low-phototoxic efficiency. However, the oxidation products of A2E that are formed in the dark or when exposed to visible, mostly blue light seem to be more toxic than A2E itself (194,217,223). They could not only accelerate further A2E oxidation process in lipofuscin granules but also affect biomolecules in the RPE cells and contribute to observed retinal pigment epithelial photodamage and maculopathy.

Xenobiotic Agents

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

“Xenobiotic” light sources

In addition to sunlight, some artificial light sources, particularly those that are used for phototherapy of seasonal affective disorder (SAD) (224–227) or circadian imbalance (228,229), may enhance normal age-related light damage to the eye. A light box adjusted to eye level is often used to administer between 2500 and 10 000 lux from the light source. These “full spectrum” light sources if not properly filtered may emit UV radiation and/or intense light in the 430 nm +/− regions (6). Phototherapeutic modification of the human circadian response can be of value (230), but only the action spectra (wavelength efficiency) 480 ± 20 nm is necessary to trigger an alert circadian response. Wavelengths lower than this are of no therapeutic value and put the patients over 40 years of age at risk for impaired vision and future retinal and macular degeneration (2).

It is also essential to remove very short blue visible light (400–440 nm) (2) from all therapeutic light sources (229), as these wavelengths of light present a risk of retinal damage to patients above 40 years old (2).

“Xenobiotic” drugs, nanoparticles and herbal supplements

The presence of a pharmaceutical or nutraceutical agent or nanoparticle, which crosses blood–retinal barrier (231) and absorbs light can severely damage the retina. The degree to which a particular exogenous photosensitizing substance is capable of producing phototoxic and toxic side effects in the retina depends on its chemical and photobiophysical parameters including: (l) the chemical structure; (2) the absorption spectrum of the drug; (3) the ability to cross blood–retinal barrier (amphiphilic or lipophilic drugs); and (4) binding of the drug to retinal tissue (proteins, melanin, DNA; Table 4). For instance, compounds that have either a tricyclic, heterocyclic or porphyrin ring structure, have absorption spectra above 400 nm and are incorporated into retinal tissues are potentially phototoxic agents to the retina (24).

Table 4.   Properties of potential phototoxic sensitizers in the retina.
Absorption spectrum
 λ > 295 nm lens
 λ > 400 nm retina
Binding
 DNA, melanin
Chemical structure
 Heterocyclic
 Tricyclic
 Porphyrin
 Nanoparticles
Cross blood–retinal barriers
 Amphiphilic/lipophilic

PDT therapeutic drugs

Photodynamic therapy (PDT) is based on inducing a photooxidation in a tumor or cancer cell by systemically injecting a highly phototoxic dye, which will be (hopefully) taken up selectively by a tumor. Subsequent laser irradiation of the dye infused tumor with the radiation at the absorbance spectra of the drug will induce a strong photooxidation in the tumor cells. PDT has been used to treat ocular melanoma (232), but has been associated with side effects including neovascular glaucoma (233). Encapsulating PDT dyes in heat-sensitive liposomes that are released by the laser increases selectivity (234) and reduces potential side effects. The combination of PDT therapy of ocular melanoma with concurrent use of photoradio-therapy (235) has been found to increase effectiveness of treatment and decrease recurrence of metastasis.

PDT is broadly used in current clinical setting in the treatment of several retinal degenerative diseases, including wet macular degeneration, choroidal neovascularization (236) and polypoidal choroidal vasculopathy (PCV) (237). In that case, the dye is injected directly into the retina, and the subsequent photooxidation reaction directs a laser to destroy the excessive blood vessels (angiogenesis) that are the cause of the damage to the retina caused by wet macular degeneration (238). Combination therapy using anti-VEGF drugs concurrent with PDT therapy (239) has been effective at delaying the necessity for repeat treatment.

Nanoparticles

Nanoparticles have been recently studied as drug carriers to first bypass blood ocular barriers and then to release encapsulated drug into various compartments of the eye. However, there are few studies that exam the potential ocular cytotoxicity and phototoxicity of these newly engineered compounds.

For instance, the water-soluble nanoparticle hydroxylated fullerene [fullerol, nano-C60(OH)22–26] has several clinical applications. Water-soluble fullerene nanoparticles can bypass the blood–brain and –retina barriers (240). Nanoparticle delivery of photosensitizers to ocular (and dermal) cells improves photodynamic therapy of tumors (241). Nanoparticles also show promise as drug carriers to the retina (242–246) and are currently being developed as carriers for antiangiogenesis drugs and vectors for gene delivery to retinal pigment epithelial cells (247,248), for treatment of wet macular degeneration. It has been shown that a single intravitreous injection of aliphatic nanoparticles preferentially localizes in retinal pigment epithelial cells (248,249), and that these nanoparticles are retained by RPE cells for a significant period of time (248,249). Unfortunately, fullerol is both cytotoxic and phototoxic to human lens epithelial cells (HLE B-3) (250) and human retinal pigment epithelial cells (251).

Nanotoxicity studies must consider the relationship between distribution particle size, surface area, composition, reactivity, coatings, stability and propensity to agglomerate or aggregate in different media (252,253) and cytotoxicity and phototoxicity. Time-resolved microspectrofluorimetry and time-gated fluorescence imaging has been used to investigate fullerol distribution and toxicity in human lens and retina cells in vitro (254). It was found that the fluorescence lifetimes change slightly, but gradually with fullerol dose, and the average fluorescence intensity appears to correlate with the onset of cytotoxicity. Other studies have shown that aggregation appears to decrease phototoxicity of fullerene nanoparticles (241) and silica nanoparticles (255). Studies of nano-TiO2 of different primary particle sizes and crystal structures found that phototoxicity to human retinal cells were directly correlated with particle surface area, and indirectly correlated with primary particle size (256).

Nanoparticles have great potential for therapeutic applications, especially for drug delivery to ocular compartments. However, for nanoparticles to be of safe clinical use their physical characteristics must be correlated with cytotoxicity and phototoxicity to ocular tissues.

St. John’s wort—hypericin

Hypericin is a biologically active component of St. John’s wort (SJW), an over-the-counter dietary supplement that has antidepressant properties (257,258). The Hypericum perforatum extract has also been associated with side effects and interactions with other drugs (259). It crosses the blood–retinal barrier and accumulates in the human retina. When ingested or given by intravitreal injection for the photodynamic treatment of retinal neovascularization, hypericin accumulates in the retina at a concentration of 1–100 μm (260). Hypericin induces cytotoxic damage (apoptosis) in retinal pigment epithelial (261).

Hypericin is known to be a very efficient photosensitizer when irradiated with either UV or visible light (262). St. John’s wort and hypericin induce photosensitized erythema in the skin (263,264). In vitro studies suggest it will induce phototoxic damage to the lens (265). Fluorescence and fluorescence imaging studies have determined that hypericin is taken up by both human lens and retinal epithelial cells (266,267). In vitro studies have determined that hypericin damages human RPE cells by inducing oxidative stress and lipid peroxidation in these cells (268).

Indocyanine green

Indocyanine green (ICG) a fluorescent dye whose absorbance spectrum is above 600 nm, assists the peeling of the internal limiting membrane during vitreoretinal surgery. This dye significantly improves the internal limiting membranes’s visibility and has made this technique much easier and more accurate. Unfortunately, ICG has also been associated with clinical damage of the the RPE.

In vitro studies (269) have shown that ICG (0.5%, 5 min) in the presence of visible energy (1.0, 3.0 and 10.0 J cm−2) comparable to an operating microscope lamp produced phototoxic effects on cultured human RPE. However, if the RPE cells were incubated with lutein (20 μm) an endogenous quencher of free radicals ROS (270,271), before ICG and visible light irradiation, there was significantly less RPE damage.

This has direct translational applications. Clinical damage of RPE caused by phototoxic effects of ICG may be reduced or eliminated by avoidance of illumination during ICG application, reducing the light intensity while dissecting the internal limiting membrane, taking care to avoid shining the light directly at the macular hole and maintaining an adequate distance between the light source and the retinal surface; and preoperative oral administration of lutein (10 mg per day) for several days. This has been found to be very effective at eliminating phototoxic damage to RPE cells during surgery (D-N Hu, unpublished data).

Conclusion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

In conclusion, we have known for many years that direct ocular exposure to sunlight is hazardous to the eye in general and the retina in particular. We now understand that it is not only UV radiation exposure that is hazardous to the eye but also visible light ambient radiation that endangers the eye, especially if the recipient is over 40 years of age. Recent research has defined the action spectrum (400–440 nm) of light that is a particular risk for triggering or exacerbating macular and retinal degeneration. After the age of 40 there is a decrease in naturally protective antioxidant systems and an increase in visible light absorbing endogenous phototoxic chromophores. The presence of drugs, herbal supplements or nanoparticles that cross blood–retinal barrier and absorb ambient light dramatically enhances visible light damage to the retina. If short blue (400–440 nm) wavelengths are filtered by sunglasses or intraocular lenses, the blue light hazard should be dramatically decreased. However, it is important not to remove 480 nm, which is essential to triggering circadian rhythm (230). Understanding the proper use and improper exposure of light directed toward the eye can significantly reduce or retard age-related ocular disease.

Author Biographies

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References

Albert Wielgus received his PhD in Biophysics from Jagiellonian University (Poland). He then joined the National Institute of Environmental Health Sciences, NIH (USA) where he was a postdoctoral fellow. Currently he works as Research Associate Senior in Duke Eye Center at Duke University School of Medicine (USA). His scientific research interests include photodamage to the human retina induced by endogenous agents (retinoids and lipofuscin) and environmental xenobiotics (hydroquinone, nanoparticles and plant-derived photosensitizers) and a role of polyunsaturated fatty acids, cholesterol and melanin in oxidative injury in the ocular tissues.

inline image

Joan E. Roberts

Joan Roberts is a tenured Professor of Chemistry at Fordham University in the Department of Natural Sciences. Her main area of expertise is the positive and negative effects of light on the human eye. With her collaborators in New York Eye and Ear Infirmary, New York, Milan, Italy; Shanghai, China; Brookhaven National Laboratories, Long Island and the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina, she studies how UV and blue visible light enhance the formation of cataracts and macular degeneration and studies ways of preventing these age-related diseases. Dr. Roberts also studies how modification of circadian rhythm influences the human immune system, jet lag and mood (seasonal depression). In addition to over 90 publications in peer reviewed scientific journals, Joan’s work has been published in several prominent “lay journals” including New Scientist, Eye World, Scientificamerica.com and Sky and Telescope. Joan has been featured on ABC World News Tonight with Bill Blakemore for her research on melatonin/circadian immune responses and the Brian Lehr show on NPR about her research on “Lighting and Human Health”.

References

  1. Top of page
  2. Abstract
  3. Introduction
  4. Endogenous Chromophores
  5. All-trans-Retinal
  6. A2E
  7. Retinal and A2E Derivatives
  8. Xenobiotic Agents
  9. Conclusion
  10. Author Biographies
  11. References
  • 1
    Commission Internationale de L’Eclairage (CIE) (1987) International lighting vocabulary. InCIE Publication No. 17.4 (Edited by Bureau Central de la Commision Electrotechnique Internationale), pp. 1379, Geneva.
  • 2
    Roberts, J. E. (2001) Ocular phototoxicity. J. Photochem. Photobiol. B 64(2-3), 136143.
  • 3
    Sliney, D. (2005) Exposure geometry and spectral environment determine photobiological effects on the human eye. Photochem. Photobiol. 81, 483489.
  • 4
    Coroneo, M. T. (1990) Albedo concentration in the anterior eye: a phenomenon that locates some solar diseases. Ophthalmic Surg. 21(1), 6066.
  • 5
    Norval, M., A. P. Cullen, F. R. de Gruijl, J. Longstreth, Y. Takizawa, R. M. Lucas, F. P. Noonan and J. C. van der Leun (2007) The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem. Photobiol. Sci. 6(3), 232251.
  • 6
    Klein, R. S., V. P. Werth, J. C. Dowdy and R. M. Sayre (2009) Analysis of compact fluorescent lights for use by patients with photosensitive conditions. Photochem. Photobiol. 85(4), 10041010.
  • 7
    Samiec, P. S., C. Drews-Botsch, E. W. Flagg, J. C. Kurtz, P. Sternberg Jr, R. L. Reed and D. P. Jones (1998) Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 24(5), 699704.
  • 8
    Vandewoude, M. F. and M. G. Vandewoude (1987) Vitamin E status in a normal population: the influence of age. J. Am. Coll. Nutr. 6(4), 307311.
  • 9
    Bachem, A. (1956) Ophthalmic ultraviolet action spectra. Am. J. Ophthalmol. 41, 969975.
  • 10
    Cullen, A. P. (2002) Photokeratitis and other phototoxic effects on the cornea and conjunctiva. Int. J. Toxicol. 21(6), 455464.
  • 11
    Barker, F. M., G. C. Brainard and P. Dayhaw-Barker (1991) Transmission of the human lens as a function of age. Invest. Ophthalmol. Vis. Sci. 32S, 1083.
  • 12
    Kuszak, J. R., K. L. Peterson, J. G. Sivak and K. L. Herbert (1994) The interrelationship of lens anatomy and optical quality. II. Primate lenses. Exp. Eye Res. 59(5), 521535.
  • 13
    Dillon, J. and S. J. Atherton (1990) Time resolved spectroscopic studies on the intact human lens. Photochem. Photobiol. 51(4), 465468.
  • 14
    Khachik, F., P. S. Bernstein and D. L. Garland (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 38, 18021811.
  • 15
    Aonuma, H., K. Koide, K. Masuda and I. Watanabe (1997) Retinal light damage: protective effect of alpha-tocopherol. Jpn. J. Ophthalmol. 41, 160167.
  • 16
    Guajardo, M., A. Terrasa and A. Catala (1999) The effect of alpha tocopherol, all-trans retinol and retinyl palmitate on the non enzymatic lipid peroxidation of rod outer segments. Mol. Cell. Biochem. 197(1-2), 173178.
  • 17
    Tate, D. J. and D. A. Newsome (2006) A novel zinc compound (zinc monocysteine) enhances the antioxidant capacity of human retinal pigment epithelial cells. Curr. Eye Res. 31(7-8), 675683.
  • 18
    Bernstein, P. S., D. Y. Zhao, S. W. Wintch, I. V. Ermakov, R. W. McClane and W. Gellermann (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109(10), 17801787.
  • 19
    (2009) Macular pigment and healthy vision. Optometry 80(10), 592598.
  • 20
    Suter, M., C. Reme, C. Grimm, A. Wenzel, M. Jaattela, P. Esser, N. Kociok, M. Leist and C. Richter (2000) Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275(50), 3962539630.
  • 21
    Hu, D. N., J. D. Simon and T. Sarna (2008) Role of ocular melanin in ophthalmic physiology and pathology. Photochem. Photobiol. 84(3), 639644.
  • 22
    Roberts, J. E., E. L. Finley, S. A. Patat and K. L. Schey (2001) Photooxidation of lens proteins with xanthurenic acid: a putative chromophore for cataractogenesis. Photochem. Photobiol. 74, 740744.
  • 23
    Thiagarajan, G., E. Shirao, K. Ando, A. Inoue and D. Balasubramanian (2002) Role of xanthurenic acid 8-O-beta-d-glucoside, a novel fluorophore that accumulates in the brunescent human eye lens. Photochem. Photobiol. 76(3), 368372.
  • 24
    Roberts, J. E. (2002) Screening for ocular phototoxicity. Int. J. Toxicol. 21, 491500.
  • 25
    Strauss, O. (2005) The retinal pigment epithelium in visual function. Physiol. Rev. 85, 845881.
  • 26
    Ripps, H. (2010) Light to sight: milestones in phototransduction. FASEB J. 24(4), 970975.
  • 27
    LaVail, M. M. (1973) Kinetics of rod outer segment renewal in the developing mouse retina. J. Cell Biol. 58, 650661.
  • 28
    Feeney, L. (1978) Lipofuscin and melanin of human retinal pigment epithelium. Fluorescence, enzyme cytochemical, and ultrastructural studies. Invest. Ophthalmol. Vis. Sci. 17(7), 583600.
  • 29
    Horton, J. D., N. A. Shah, J. A. Warrington, N. N. Anderson, S. W. Park, M. S. Brown and J. L. Goldstein (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. U.S.A. 100, 1202712032.
  • 30
    Ishibashi, K., J. Tian and J. T. Handa (2004) Similarity of mRNA phenotypes of morphologically normal macular and peripheral retinal pigment epithelial cells in older human eyes. Invest. Ophthalmol. Vis. Sci. 45, 32913301.
  • 31
    Dillon, J. (1991) The photophysics and photobiology of the eye. J. Photochem. Photobiol. B 10, 2340.
  • 32
    Noell, W. K. (1980) Possible mechanisms of photoreceptor damage by light in mammalian eyes. Vision. Res. 20(12), 11631171.
  • 33
    Wielgus, A. R., R. J. Collier, E. Martin, F. B. Lih, K. B. Tomer, C. F. Chignell and J. E. Roberts (2010) Blue light induced A2E oxidation in rat eyes—experimental animal model of dry AMD. Photochem. Photobiol. Sci. 9(11), 15051512.
  • 34
    Taylor, H. R., S. West, B. Munoz, F. S. Rosenthal, S. B. Bressler and N. M. Bressler (1992) The long-term effects of visible light on the eye. Arch. Ophthalmol. 110(1), 99104.
  • 35
    Boulton, M. and P. Dayhaw-Barker (2001) The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye (Lond.) 15, 384389.
  • 36
    Glickman, R. D. (2002) Phototoxicity to the retina: mechanisms of damage. Int. J. Toxicol. 21(6), 473490.
  • 37
    Ham Jr, W. T., J. J. Ruffolo Jr, H. A. Mueller, A. M. Clarke and M. E. Moon (1978) Histologic analysis of photochemical lesions produced in rhesus retina by short-wave-length light. Invest. Ophthalmol. Vis. Sci. 17(10), 10291035.
  • 38
    Marc, R. E., B. W. Jones, C. B. Watt, F. Vazquez-Chona, D. K. Vaughan and D. T. Organisciak (2008) Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol. Vis. 14, 782806.
  • 39
    Margrain, T. H., M. Boulton, J. Marshall and D. H. Sliney (2004) Do blue light filters confer protection against age-related macular degeneration? Prog. Retin. Eye Res. 23(5), 523531.
  • 40
    Ueda, T., T. Nakanishi-Ueda, H. Yasuhara, R. Koide and W. W. Dawson (2009) Eye damage control by reduced blue illumination. Exp. Eye Res. 89(6), 863868.
  • 41
    Agarwal, N., E. Martin, R. R. Krishnamoorthy, R. Landers, R. Wen, S. Krueger, M. A. Kapin and R. J. Collier (2002) Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy. Exp. Eye Res. 74(4), 445453.
  • 42
    Ham, W. T. Jr, H. A. Mueller, J. J. Ruffolo Jr, J. E. Millen, S. F. Cleary, R. K. Guerry and D. Guerry 3rd (1984) Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr. Eye Res. 3(1), 165174.
  • 43
    Ruffolo Jr, J. J., W. T. Ham Jr, H. A. Mueller and J. E. Millen (1984) Photochemical lesions in the primate retina under conditions of elevated blood oxygen. Invest. Ophthalmol. Vis. Sci. 25(8), 893898.
  • 44
    Organisciak, D. T. and B. S. Winkler (1994) Retinal light damage: practical and theoretical considerations. Prog. Retin. Eye Res. 13(1), 129.
  • 45
    Organisciak, D. T. and D. K. Vaughan (2010) Retinal light damage: mechanisms and protection. Prog. Retin. Eye Res. 29(2), 113134.
  • 46
    Grimm, C., C. E. Reme, P. O. Rol and T. P. Williams (2000) Blue light’s effects on rhodopsin: photoreversal of bleaching in living rat eyes. Invest. Ophthalmol. Vis. Sci. 41(12), 39843990.
  • 47
    Grimm, C., A. Wenzel, T. Williams, P. Rol, F. Hafezi and C. Reme (2001) Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest. Ophthalmol. Vis. Sci. 42(2), 497505.
  • 48
    Boulton, M., M. Rozanowska and B. Rozanowski (2001) Retinal photodamage. J. Photochem. Photobiol. B 64(2-3), 144161.
  • 49
    Sparrow, J. R., Y. Wu, C. Y. Kim and J. Zhou (2010) Phospholipid meets all-trans-retinal: the making of RPE bis-retinoids. J. Lipid Res. 51(2), 247261.
  • 50
    Lubart, R., Y. Wollman, H. Friedmann, S. Rochkind and I. Laulicht (1992) Effects of visible and near-infrared lasers on cell cultures. J. Photochem. Photobiol. B 12(3), 305310.
  • 51
    King, A., E. Gottlieb, D. G. Brooks, M. P. Murphy and J. L. Dunaief (2004) Mitochondria-derived reactive oxygen species mediate blue light-induced death of retinal pigment epithelial cells. Photochem. Photobiol. 79(5), 470475.
  • 52
    Chen, E. (1993) Inhibition of cytochrome oxidase and blue-light damage in rat retina. Graefes Arch. Clin. Exp. Ophthalmol. 231(7), 416423.
  • 53
    Chen, E. (1993) Inhibition of enzymes by short-wave optical radiation and its effect on the retina. Acta Ophthalmol. Suppl. 208, 148.
  • 54
    Chen, E., J. Pallon and B. Forslind (1995) Distribution of calcium and sulphur in the blue-light-exposed rat retina. Graefes Arch. Clin. Exp. Ophthalmol. 233(3), 163167.
  • 55
    Wu, J., A. Gorman, X. Zhou, C. Sandra and E. Chen (2002) Involvement of caspase-3 in photoreceptor cell apoptosis induced by in vivo blue light exposure. Invest. Ophthalmol. Vis. Sci. 43(10), 33493354.
  • 56
    Harper, W. S. and E. R. Gaillard (2001) Studies of all-trans-retinal as a photooxidizing agent. Photochem. Photobiol. 73, 7176.
  • 57
    Pawlak, A., M. Wrona, M. Różanowska, M. Zaręba, L. E. Lamb, J. E. Roberts, J. D. Simon and T. Sarna (2003) Comparison of the aerobic photoreactivity of A2E with its precursor retinal. Photochem. Photobiol. 77, 253258.
  • 58
    Maeda, A., T. Maeda, M. Golczak, S. Chou, A. Desai, C. L. Hoppel, S. Matsuyama and K. Palczewski (2009) Involvement of all-trans-retinal in acute light-induced retinopathy of mice. J. Biol. Chem. 284, 1517315183.
  • 59
    Różanowska, M., J. Jarvis-Evans, W. Korytowski, M. E. Boulton, J. M. Burke and T. Sarna (1995) Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J. Biol. Chem. 270(32), 1882518830.
  • 60
    Różanowska, M., J. Wessels, M. Boulton, J. M. Burke, M. A. Rodgers, T. G. Truscott and T. Sarna (1998) Blue light-induced singlet oxygen generation by retinal lipofuscin in non-polar media. Free Radic. Biol. Med. 24(7-8), 11071112.
  • 61
    Pawlak, A., M. Różanowska, M. Zaręba, L. E. Lamb, J. D. Simon and T. Sarna (2002) Action spectra for the photoconsumption of oxygen by human ocular lipofuscin and lipofuscin extracts. Arch. Biochem. Biophys. 403(1), 5962.
  • 62
    Boulton, M., M. Różanowska and T. Wess (2004) Ageing of the retinal pigment epithelium: implications for transplantation. Graefes Arch. Clin. Exp. Ophthalmol. 242(1), 7684.
  • 63
    Lee, P. P., Z. W. Feldman, J. Ostermann, D. S. Brown and F. A. Sloan (2003) Longitudinal prevalence of major eye diseases. Arch. Ophthalmol. 121(9), 13031310.
  • 64
    Friedman, D. S., B. J. O’Colmain, B. Munoz, S. C. Tomany, C. McCarty, P. T. de Jong, B. Nemesure, P. Mitchell and J. Kempen (2004) Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122(4), 564572.
  • 65
    Klein, R., B. E. Klein and K. L. Linton (1992) Prevalence of age-related maculopathy. The Beaver Dam eye study. Ophthalmology 99(6), 933943.
  • 66
    Klein, R., B. E. Klein, S. C. Tomany, S. M. Meuer and G. H. Huang (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109(10), 17671779.
  • 67
    Vingerling, J. R., I. Dielemans, A. Hofman, D. E. Grobbee, M. Hijmering, C. F. Kramer and P. T. de Jong (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102(2), 205210.
  • 68
    Vingerling, J. R., C. C. Klaver, A. Hofman and P. T. de Jong (1995) Epidemiology of age-related maculopathy. Epidemiol. Rev. 17(2), 347360.
  • 69
    Mitchell, P., W. Smith, K. Attebo and J. J. Wang (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains eye study. Ophthalmology 102(10), 14501460.
  • 70
    Algvere, P. V. and S. Seregard (2002) Age-related maculopathy: pathogenetic features and new treatment modalities. Acta Ophthalmol. Scand. 80, 136143.
  • 71
    Smith, W., J. Assink, R. Klein, P. Mitchell, C. C. Klaver, B. E. Klein, A. Hofman, S. Jensen, J. J. Wang and P. T. de Jong (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108(4), 697704.
  • 72
    Husain, D., B. Ambati, A. P. Adamis and J. W. Miller (2002) Mechanisms of age-related macular degeneration. Ophthalmol. Clin. North Am. 15(1), 8791.
  • 73
    Kinnunen, K., G. Petrovski, M. C. Moe, A. Berta and K. Kaarniranta (2012) Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol. 90, 299309.
  • 74
    Young, R. W. (1988) Solar radiation and age-related macular degeneration. Surv. Ophthalmol. 32(4), 252269.
  • 75
    Cruickshanks, K. J., R. Klein and B. E. Klein (1993) Sunlight and age-related macular degeneration. The Beaver Dam eye study. Arch. Ophthalmol. 111(4), 514518.
  • 76
    Tomany, S. C., K. J. Cruickshanks, R. Klein, B. E. Klein and M. D. Knudtson (2004) Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch. Ophthalmol. 122(5), 750757.
  • 77
    Tomany, S. C., K. J. Cruickshanks, R. Klein, B. E. Klein and M. D. Knudtson (2005) Correction to “Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study”. Arch. Ophthalmol. 123, 362.
  • 78
    Plestina-Borjan, I. and M. Klinger-Lasic (2007) Long-term exposure to solar ultraviolet radiation as a risk factor for age-related macular degeneration. Coll. Antropol. 31(Suppl. 1), 3338.
  • 79
    Darzins, P., P. Mitchell and R. F. Heller (1997) Sun exposure and age-related macular degeneration. An Australian case–control study. Ophthalmology 104(5), 770776.
  • 80
    Hyman, L. G., A. M. Lilienfeld, F. L. Ferris 3rd and S. L. Fine (1983) Senile macular degeneration: a case–control study. Am. J. Epidemiol. 118(2), 213227.
  • 81
    Age-Related Eye Disease Study Research Group (2000) Risk factors associated with age-related macular degeneration. A case–control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 107, 22242232.
  • 82
    Age-Related Eye Disease Study Research Group (2009) Age-related eye disease study 2 (AREDS2) protocol https://web.emmes.com/study/areds2/resources/areds2_protocol.pdf .
  • 83
    Fletcher, A. E., G. C. Bentham, M. Agnew, I. S. Young, C. Augood, U. Chakravarthy, P. T. de Jong, M. Rahu, J. Seland, G. Soubrane, L. Tomazzoli, F. Topouzis, J. R. Vingerling and J. Vioque (2008) Sunlight exposure, antioxidants, and age-related macular degeneration. Arch. Ophthalmol. 126(10), 13961403.
  • 84
    Evans, J. (2008) Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond.) 22(6), 751760.
  • 85
    Winkler, B. S., M. E. Boulton, J. D. Gottsch and P. Sternberg (1999) Oxidative damage and age-related macular degeneration. Mol. Vis. 5, 32.
  • 86
    Beatty, S., H. Koh, M. Phil, D. Henson and M. Boulton (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45(2), 115134.
  • 87
    Glazer, L. C. and T. P. Dryja (2002) Understanding the etiology of Stargardt’s disease. Ophthalmol. Clin. North. Am. 15(1), 93100, viii.
  • 88
    Sundelin, S., U. Wihlmark, S. E. Nilsson and U. T. Brunk (1998) Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. Curr. Eye Res. 17(8), 851857.
  • 89
    Ng, K. P., B. Gugiu, K. Renganathan, M. W. Davies, X. Gu, J. S. Crabb, S. R. Kim, M. B. Rozanowska, V. L. Bonilha, M. E. Rayborn, R. G. Salomon, J. R. Sparrow, M. E. Boulton, J. G. Hollyfield and J. W. Crabb (2008) Retinal pigment epithelium lipofuscin proteomics. Mol. Cell. Proteomics 7(7), 13971405.
  • 90
    Dorey, C. K., G. Wu, D. Ebenstein, A. Garsd and J. J. Weiter (1989) Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest. Ophthalmol. Vis. Sci. 30(8), 16911699.
  • 91
    Boulton, M., F. Docchio, P. Dayhaw-Barker, R. Ramponi and R. Cubeddu (1990) Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision. Res. 30(9), 12911303.
  • 92
    Katz, M. L., C. L. Gao and L. M. Rice (1996) Formation of lipofuscin-like fluorophores by reaction of retinal with photoreceptor outer segments and liposomes. Mech. Ageing Dev. 92(2-3), 159174.
  • 93
    Feeney-Burns, L., E. R. Berman and H. Rothman (1980) Lipofuscin of human retinal pigment epithelium. Am. J. Ophthalmol. 90(6), 783791.
  • 94
    Brunk, U. T., U. Wihlmark, A. Wrigstad, K. Roberg and S. E. Nilsson (1995) Accumulation of lipofuscin within retinal pigment epithelial cells results in enhanced sensitivity to photo-oxidation. Gerontology 41(Suppl. 2), 201212.
  • 95
    Brunk, U. T. and A. Terman (2002) Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33(5), 611619.
  • 96
    Biesemeier, A., U. Schraermeyer and O. Eibl (2011) Chemical composition of melanosomes, lipofuscin and melanolipofuscin granules of human RPE tissues. Exp. Eye Res. 93(1), 2939.
  • 97
    Clancy, C. M. R., J. R. Krogmeier, A. Pawlak, M. Różanowska, T. Sarna, R. C. Dunn and J. D. Simon (2000) Atomic force microscopy and near-field scanning optical microscopy measurements of single human retinal lipofuscin granules. J. Phys. Chem. 104, 1209812101.
  • 98
    Haralampus-Grynaviski, N. M., L. E. Lamb, J. D. Simon, J. R. Krogmeier, R. C. Dunn, A. Pawlak, M. Rozanowska, T. Sarna and J. M. Burke (2001) Probing the spatial dependence of the emission spectrum of single human retinal lipofuscin granules using near-field scanning optical microscopy. Photochem. Photobiol. 74(2), 364368.
  • 99
    Warburton, S., K. Southwick, R. M. Hardman, A. M. Secrest, R. K. Grow, H. Xin, A. T. Woolley, G. F. Burton and C. D. Thulin (2005) Examining the proteins of functional retinal lipofuscin using proteomic analysis as a guide for understanding its origin. Mol. Vis. 11, 11221134.
  • 100
    Krogmeier, J. R., C. M. Clancy, A. Pawlak, M. Rozanowska, T. Sarna, J. D. Simon and R. C. Dunn (2001) Mapping the distribution of emissive molecules in human ocular lipofuscin granules with near-field scanning optical microscopy. J. Microsc. 202, 386390.
  • 101
    Haralampus-Grynaviski, N. M., L. E. Lamb, C. M. Clancy, C. Skumatz, J. M. Burke, T. Sarna and J. D. Simon (2003) Spectroscopic and morphological studies of human retinal lipofuscin granules. Proc. Natl. Acad. Sci. U.S.A. 100(6), 31793184.
  • 102
    Eldred, G. E. and M. R. Lasky (1993) Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 361(6414), 724726.
  • 103
    Delori, F. C., D. G. Goger and C. K. Dorey (2001) Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest. Ophthalmol. Vis. Sci. 42(8), 18551866.
  • 104
    Weiter, J. J., F. C. Delori, G. L. Wing and K. A. Fitch (1986) Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest. Ophthalmol. Vis. Sci. 27(2), 145152.
  • 105
    Różanowska, M., W. Korytowski, B. Rozanowski, C. Skumatz, M. E. Boulton, J. M. Burke and T. Sarna (2002) Photoreactivity of aged human RPE melanosomes: a comparison with lipofuscin. Invest. Ophthalmol. Vis. Sci. 43(7), 20882096.
  • 106
    Warburton, S., W. E. Davis, K. Southwick, H. Xin, A. T. Woolley, G. F. Burton and C. D. Thulin (2007) Proteomic and phototoxic characterization of melanolipofuscin: correlation to disease and model for its origin. Mol. Vis. 13, 318329.
  • 107
    Gouras, P., L. Ivert, J. A. Mattison, D. K. Ingram and M. Neuringer (2008) Drusenoid maculopathy in rhesus monkeys: autofluorescence, lipofuscin and drusen pathogenesis. Graefes Arch. Clin. Exp. Ophthalmol. 246(10), 14031411.
  • 108
    Feeney-Burns, L., C. L. Gao and E. R. Berman (1988) The fate of immunoreactive opsin following phagocytosis by pigment epithelium in human and monkey retinas. Invest. Ophthalmol. Vis. Sci. 29(5), 708719.
  • 109
    Wang, L., M. E. Clark, D. K. Crossman, K. Kojima, J. D. Messinger, J. A. Mobley and C. A. Curcio (2010) Abundant lipid and protein components of drusen. PLoS ONE 5(4), e10329.
  • 110
    Holz, F. G., C. Bellmann, M. Margaritidis, F. Schutt, T. P. Otto and H. E. Volcker (1999) Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 237(2), 145152.
  • 111
    Wolf-Schnurrbusch, U. E., V. V. Wittwer, R. Ghanem, M. Niederhaeuser, V. Enzmann, C. Framme and S. Wolf (2011) Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest. Ophthalmol. Vis. Sci. 52(13), 94979502.
  • 112
    Bazan, H. E., N. G. Bazan, L. Feeney-Burns and E. R. Berman (1990) Lipids in human lipofuscin-enriched subcellular fractions of two age populations. Comparison with rod outer segments and neural retina. Invest. Ophthalmol. Vis. Sci. 31(8), 14331443.
  • 113
    Katz, M. L. and W. G. Robison Jr (2002) What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies. Arch. Gerontol. Geriatr. 34(3), 169184.
  • 114
    Nilsson, S. E., S. P. Sundelin, U. Wihlmark and U. T. Brunk (2003) Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage. Doc. Ophthalmol. 106(1), 1316.
  • 115
    Krohne, T. U., N. K. Stratmann, J. Kopitz and F. G. Holz (2010) Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp. Eye Res. 90(3), 465471.
  • 116
    Radu, R. A., Q. Yuan, J. Hu, J. H. Peng, M. Lloyd, S. Nusinowitz, D. Bok and G. H. Travis (2008) Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Invest. Ophthalmol. Vis. Sci. 49(9), 38213829.
  • 117
    Porta, E. A. (1991) Advances in age pigment research. Arch. Gerontol. Geriatr. 12(2-3), 303320.
  • 118
    Schutt, F., B. Ueberle, M. Schnolzer, F. G. Holz and J. Kopitz (2002) Proteome analysis of lipofuscin in human retinal pigment epithelial cells. FEBS Lett. 528(1-3), 217221.
  • 119
    Schutt, F., M. Bergmann, F. G. Holz and J. Kopitz (2003) Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44(8), 36633668.
  • 120
    Boulton, M., M. Różanowska, B. Różanowski and T. Wess (2004) The photoreactivity of ocular lipofuscin. Photochem. Photobiol. Sci. 3(8), 759764.
  • 121
    Renganathan, K., K. P. Ng, M. Davies, X. Gu, M. Różanowska, M. E. Rayborn, R. G. Salomon, J. G. Hollyfield, M. E. Boulton and J. W. Crabb (2007) Does lipofuscin contain protein? Amino acid, protein and ultrastructural analysis of human lipofuscin. Invest. Ophthalmol. Vis. Sci. 48, E-Abstract 5059.
  • 122
    Yin, D. (1995) Studies on age pigments evolving into a new theory of biological aging. Gerontology 41(Suppl. 2), 159172.
  • 123
    Sparrow, J. R. and M. Boulton (2005) RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res. 80(5), 595606.
  • 124
    Sparrow, J. R., Y. Wu, T. Nagasaki, K. D. Yoon, K. Yamamoto and J. Zhou (2010) Fundus autofluorescence and the bisretinoids of retina. Photochem. Photobiol. Sci. 9(11), 14801489.
  • 125
    Marmorstein, A. D., L. Y. Marmorstein, H. Sakaguchi and J. G. Hollyfield (2002) Spectral profiling of autofluorescence associated with lipofuscin, Bruch’s membrane, and sub-RPE deposits in normal and AMD eyes. Invest. Ophthalmol. Vis. Sci. 43(7), 24352441.
  • 126
    Docchio, F., M. Boulton, R. Cubeddu, R. Ramponi and P. D. Barker (1991) Age-related changes in the fluorescence of melanin and lipofuscin granules of the retinal pigment epithelium: a time-resolved fluorescence spectroscopy study. Photochem. Photobiol. 54(2), 247253.
  • 127
    Eldred, G. E., G. V. Miller, W. S. Stark and L. Feeney-Burns (1982) Lipofuscin: resolution of discrepant fluorescence data. Science 216(4547), 757759.
  • 128
    Terman, A. and U. T. Brunk (1999) Is lipofuscin eliminated from cells? Invest. Ophthalmol. Vis. Sci. 40(10), 24632464.
  • 129
    Gaillard, E. R., S. J. Atherton, G. Eldred and J. Dillon (1995) Photophysical studies on human retinal lipofuscin. Photochem. Photobiol. 61(5), 448453.
  • 130
    Reszka, K., G. E. Eldred, R. H. Wang, C. Chignell and J. Dillon (1995) The photochemistry of human retinal lipofuscin as studied by EPR. Photochem. Photobiol. 62(6), 10051008.
  • 131
    Boulton, M., A. Dontsov, J. Jarvis-Evans, M. Ostrovsky and D. Svistunenko (1993) Lipofuscin is a photoinducible free radical generator. J. Photochem. Photobiol. B 19(3), 201204.
  • 132
    Różanowska, M., A. Pawlak, B. Różanowski, C. Skumatz, M. Zaręba, M. E. Boulton, J. M. Burke, T. Sarna and J. D. Simon (2004) Age-related changes in the photoreactivity of retinal lipofuscin granules: role of chloroform-insoluble components. Invest. Ophthalmol. Vis. Sci. 45(4), 10521060.
  • 133
    Avalle, L. B., J. Dillon, S. Tari and E. R. Gaillard (2005) A new approach to measuring the action spectrum for singlet oxygen production by human retinal lipofuscin. Photochem. Photobiol. 81, 13471350.
  • 134
    Dontsov, A. E., R. D. Glickman and M. A. Ostrovsky (1999) Retinal pigment epithelium pigment granules stimulate the photo-oxidation of unsaturated fatty acids. Free Radic. Biol. Med. 26(11-12), 14361446.
  • 135
    Wassell, J., S. Davies, W. Bardsley and M. Boulton (1999) The photoreactivity of the retinal age pigment lipofuscin. J. Biol. Chem. 274(34), 2382823832.
  • 136
    Shamsi, F. A. and M. Boulton (2001) Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest. Ophthalmol. Vis. Sci. 42(12), 30413046.
  • 137
    Davies, S., M. H. Elliott, E. Floor, T. G. Truscott, M. Zareba, T. Sarna, F. A. Shamsi and M. E. Boulton (2001) Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic. Biol. Med. 31(2), 256265.
  • 138
    Crouch, R. K., G. J. Chader, B. Wiggert and D. R. Pepperberg (1996) Retinoids and the visual process. Photochem. Photobiol. 64(4), 613621.
  • 139
    McBee, J. K., K. Palczewski, W. Baehr and D. R. Pepperberg (2001) Confronting complexicity: the interlink of phototransduction and retinoid metabolism in vertebrate retina. Prog. Retin. Eye Res. 20, 469529.
  • 140
    Imanishi, Y., M. L. Batten, D. W. Piston, W. Baehr and K. Palczewski (2004) Noninvasive two-photon imaging reveals retinyl ester storage structures in the eye. J. Cell Biol. 164(3), 373383.
  • 141
    Travis, G. H., M. Golczak, A. R. Moise and K. Palczewski (2007) Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu. Rev. Pharmacol. Toxicol. 47, 469512.
  • 142
    Maeda, A., M. Golczak, T. Maeda and K. Palczewski (2009) Limited roles of Rdh8, Rdh12, and Abca4 in all-trans-retinal clearance in mouse retina. Invest. Ophthalmol. Vis. Sci. 50(11), 54355443.
  • 143
    Lai, Y. L., A. T. Tsin, K. W. Lam and J. J. Garcia (1985) Distribution of retinoids in different compartments of the posterior segment of the rabbit eye. Brain Res. Bull. 15(2), 143147.
  • 144
    Maeda, A., T. Maeda, M. Golczak and K. Palczewski (2008) Retinopathy in mice induced by disrupted all-trans-retinal clearance. J. Biol. Chem. 283, 2668426693.
  • 145
    Sun, H. and J. Nathans (1997) Stargardt’s ABCR is localized to the disc membrane of retinal rod outer segments. Nat. Genet. 17, 1516.
  • 146
    Sun, H., R. S. Molday and J. Nathans (1999) Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J. Biol. Chem. 274, 82698281.
  • 147
    Gao, X. and P. Talalay (2004) Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl. Acad. Sci. U.S.A. 101(28), 1044610451.
  • 148
    Chrispell, J. D., K. L. Feathers, M. A. Kane, C. Y. Kim, M. Brooks, R. Khanna, I. Kurth, C. A. Hubner, A. Gal, A. J. Mears, A. Swaroop, J. L. Napoli, J. R. Sparrow and D. A. Thompson (2009) Rdh12 activity and effects on retinoid processing in the murine retina. J. Biol. Chem. 284, 2146821477.
  • 149
    Maeda, T., A. Maeda, P. Leahy, D. A. Saperstein and K. Palczewski (2009) Effects of long-term administration of 9-cis-retinyl acetate on visual function in mice. Invest. Ophthalmol. Vis. Sci. 50(1), 322333.
  • 150
    Saari, J. C., G. G. Garwin, J. P. Van Hooser and K. Palczewski (1998) Reduction of all-trans-retinal limits regeneration of visual pigment in mice. Vision. Res. 38, 13251333.
  • 151
    Yang, M. and H. K. Fong (2002) Synthesis of the all-trans-retinal chromophore of retinal G protein-coupled receptor opsin in cultured pigment epithelial cells. J. Biol. Chem. 277(5), 33183324.
  • 152
    Katz, M. L. and T. M. Redmond (2001) Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 42(12), 30233030.
  • 153
    Tolleson, W. H., S. H. Cherng, Q. Xia, M. Boudreau, J. J. Yin, W. G. Wamer, P. C. Howard, H. Yu and P. P. Fu (2005) Photodecomposition and phototoxicity of natural retinoids. Int. J. Environ. Res. Public Health 2, 147155.
  • 154
    Wielgus, A. R., C. F. Chignell, P. Ceger and J. E. Roberts (2010) Comparison of A2E cytotoxicity and phototoxicity with all-trans-retinal in human retinal pigment epithelial cells. Photochem. Photobiol. 86(4), 781791.
  • 155
    Siems, W., O. Sommerburg, L. Schild, W. Augustin, C. D. Langhans and I. Wiswedel (2002) Beta-carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J. 16, 12891291.
  • 156
    Różanowski, B., M. B. Różanowska and M. E. Boulton (2003) Toxicity of all-trans retinal to the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44, E-Abstract 1643.
  • 157
    Baron, M. H., M. J. Coulange, C. Coupry, D. Baron, J. Favrot and M. M. Abo Aly (1989) All-trans retinal photoisomerization and photooxidation from UV laser radiation. Vibrational assignment of all-trans 5,8-peroxyretinal. Photochem. Photobiol. 49, 739751.
  • 158
    Loginova, M. Y., Y. V. Rostovtseva, T. B. Feldman and M. A. Ostrovsky (2008) Light damaging action of all-trans-retinal and its derivatives on rhodopsin molecules in the photoreceptor membrane. Biochemistry (Mosc.) 73(2), 130138.
  • 159
    Dillon, J., E. R. Gaillard, P. Bilski, C. F. Chignell and K. J. Reszka (1996) The photochemistry of the retinoids as studied by steady-state and pulsed methods. Photobiol. Photochem. 63(5), 680685.
  • 160
    Różanowska, M. B., R. Edge, E. T. Land, S. Navaratnam, T. G. Truscott and B. Różanowski (2007) Free radical interactions of retinal constituents—retinaldehyde and its adducts with phosphatidylethanolamine. Invest. Ophthalmol. Vis. Sci. 48, E-Abstract 3258.
  • 161
    Ostrovskii, M. A. and I. B. Fedorovich (1994) [Retinal as a photo-damage sensitizer of retinal-containing retina proteins]. Biofizika 39, 1325.
  • 162
    Sun, H. and J. Nathans (2001) ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-trans-retinal-mediated photooxidative damage in vitro. Implications for retinal disease. J. Biol. Chem. 276, 1176611774.
  • 163
    Fedorovich, I. B., E. M. Semenova, K. Grant, C. A. Converse and M. A. Ostrovsky (2000) Photosensitized light-induced damage of IRBP (interphotoreceptor retinoid-binding protein): effects on binding properties. Curr. Eye Res. 21, 975980.
  • 164
    Kanan, Y., G. Moiseyev, N. Agarwal, J. X. Ma and M. R. Al-Ubaidi (2007) Light induces programmed cell death by activating multiple independent proteases in a cone photoreceptor cell line. Invest. Ophthalmol. Vis. Sci. 48, 4051.
  • 165
    Sakai, N., J. Decatur, K. Nakanishi and G. E. Eldred (1996) Ocular age pigment “A2-E”: an unprecedented pyridinium bisretinoid. J. Am. Chem. Soc. 118, 15591560.
  • 166
    Mata, N. L., J. Weng and G. H. Travis (2000) Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 97(13), 17151759.
  • 167
    Eldred, G. E. (1993) Age pigment structure. Nature 364(6436), 396.
  • 168
    Parish, C. A., M. Hashimoto, K. Nakanishi, J. Dillon and J. Sparrow (1998) Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc. Natl. Acad. Sci. U.S.A. 95(25), 1460914613.
  • 169
    Sparrow, J. R., C. A. Parish, M. Hashimoto and K. Nakanishi (1999) A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest. Ophthalmol. Vis. Sci. 40, 29882995.
  • 170
    Liu, J., Y. Itagaki, S. Ben-Shabat, K. Nakanishi and J. R. Sparrow (2000) The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J. Biol. Chem. 275(38), 2935429360.
  • 171
    Ben-Shabat, S., C. A. Parish, M. Hashimoto, J. Liu, K. Nakanishi and J. R. Sparrow (2001) Fluorescent pigments of the retinal pigment epithelium and age-related macular degeneration. Bioorg. Med. Chem. Lett. 11(12), 15331540.
  • 172
    Ben-Shabat, S., C. A. Parish, H. R. Vollmer, Y. Itagaki, N. Fishkin, K. Nakanishi and J. R. Sparrow (2002) Biosynthetic studies of A2E, a major fluorophore of retinal pigment epithelial lipofuscin. J. Biol. Chem. 277(9), 71837190.
  • 173
    Ragauskaite, L., R. C. Heckathorn and E. R. Gaillard (2001) Environmental effects on the photochemistry of A2-E, a component of human retinal lipofuscin. Photochem. Photobiol. 74(3), 483488.
  • 174
    Roberts, J. E., B. M. Kukiełczak, D. N. Hu, D. S. Miller, P. Bilski, R. H. Sik, A. G. Motten and C. F. Chignell (2002) The role of A2E in prevention or enhancement of light damage in human retinal pigment epithelial cells. Photochem. Photobiol. 75(2), 184190.
  • 175
    Schutt, F., M. Bergmann, F. G. Holz, S. Dithmar, H. E. Volcker and J. Kopitz (2007) Accumulation of A2-E in mitochondrial membranes of cultured RPE cells. Graefes Arch. Clin. Exp. Ophthalmol. 245, 391398.
  • 176
    Bhosale, P., B. Serban and P. S. Bernstein (2009) Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch. Biochem. Biophys. 483(2), 175181.
  • 177
    Wu, Y., J. Zhou, N. Fishkin, B. E. Rittmann and J. R. Sparrow (2011) Enzymatic degradation of A2E, a retinal pigment epithelial lipofuscin bisretinoid. J. Am. Chem. Soc. 133(4), 849857.
  • 178
    Lakkaraju, A., S. C. Finnemann and E. Rodriguez-Boulan (2007) The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 104(26), 1102611031.
  • 179
    Biswas-Fiss, E. E., D. S. Kurpad, K. Joshi and S. B. Biswas (2010) Interaction of extracellular domain 2 of the human retina-specific ATP-binding cassette transporter (ABCA4) with all-trans-retinal. J. Biol. Chem. 285(25), 1937219383.
  • 180
    Grey, A. C., R. K. Crouch, Y. Koutalos, K. L. Schey and Z. Ablonczy (2011) Spatial localization of A2E in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 52(7), 39263933.
  • 181
    Roberts, J. E., D.-N. Hu, K. Nakanishi, P. Taroni and R. Cubeddu (1999) Cell growth, absorbance and fluorescence changes in retinal pigment epithelium cells in the presence of A2E (putative precursor of lipofuscin). Invest. Ophthalmol. Vis. Sci. 40(4), E-Abstract 223.
  • 182
    Holz, F. G., F. Schutt, J. Kopitz, G. E. Eldred, F. E. Kruse, H. E. Volcker and M. Cantz (1999) Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest. Ophthalmol. Vis. Sci. 40(3), 737743.
  • 183
    Mata, N. L., R. T. Tzekov, X. Liu, J. Weng, D. G. Birch and G. H. Travis (2001) Delayed dark-adaptation and lipofuscin accumulation in abcr+/− mice: implications for involvement of ABCR in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 42(8), 16851690.
  • 184
    Radu, R. A., N. L. Mata, A. Bagla and G. H. Travis (2004) Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt’s macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 101(16), 59285933.
  • 185
    Cubeddu, R., P. Taroni, D.-N. Hu, N. Sakai, K. Nakanishi and J. E. Roberts (1999) Photophysical studies of A2-E, putative precursor of lipofuscin, in human retinal pigment epithelial cells. Photochem. Photobiol. 70(2), 172175.
  • 186
    Vives-Bauza, C., M. Anand, A. K. Shirazi, J. Magrane, J. Gao, H. R. Vollmer-Snarr, G. Manfredi and S. C. Finnemann (2008) The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J. Biol. Chem. 283(36), 2477024780.
  • 187
    Shaban, H., P. Gazzotti and C. Richter (2001) Cytochrome c oxidase inhibition by N-retinyl-N-retinylidene ethanolamine, a compound suspected to cause age-related macula degeneration. Arch. Biochem. Biophys. 394(1), 111116.
  • 188
    Bergmann, M., F. Schutt, F. G. Holz and J. Kopitz (2004) Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 18, 562564.
  • 189
    Finnemann, S. C., L. W. Leung and E. Rodriguez-Boulan (2002) The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc. Natl. Acad. Sci. U.S.A. 99(6), 38423847.
  • 190
    Lamb, L. E., T. Ye, N. M. Haralampus-Grynaviski, T. R. Williams, A. Pawlak, T. Sarna and J. D. Simon (2001) Primary photophysical properties of A2E in solution. J. Phys. Chem. 105, 1150711512.
  • 191
    De, S. and T. P. Sakmar (2002) Interaction of A2E with model membranes. Implications to the pathogenesis of age-related macular degeneration. J. Gen. Physiol. 120, 147157.
  • 192
    Cantrell, A., D. J. McGarvey, J. Roberts, T. Sarna and T. G. Truscott (2001) Photochemical studies of A2-E. J. Photochem. Photobiol., B 64(2-3), 162165.
  • 193
    Bynoe, L. A., L. V. Del Priore and R. Hornbeck (1998) Photosensitization of retinal pigment epithelium by protoporphyrin IX. Graefes Arch. Clin. Exp. Ophthalmol. 236(3), 230233.
  • 194
    Sparrow, J. R., H. R. Vollmer-Snarr, J. Zhou, Y. P. Jang, S. Jockusch, Y. Itagaki and K. Nakanishi (2003) A2E-epoxides damage DNA in retinal pigment epithelial cells. Vitamin E and other antioxidants inhibit A2E-epoxide formation. J. Biol. Chem. 278(20), 1820718213.
  • 195
    Kanofsky, J. R., P. D. Sima and C. Richter (2003) Singlet-oxygen generation from A2E. Photochem. Photobiol. 77(3), 235242.
  • 196
    Gaillard, E. R., L. B. Avalle, L. M. Keller, Z. Wang, K. J. Reszka and J. P. Dillon (2004) A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp. Eye Res. 79(3), 313319.
  • 197
    Broniec, A., A. Pawlak, T. Sarna, A. Wielgus, J. E. Roberts, E. J. Land, T. G. Truscott, R. Edge and S. Navaratnam (2005) Spectroscopic properties and reactivity of free radical forms of A2E. Free Radic. Biol. Med. 38, 10371046.
  • 198
    Ben-Shabat, S., Y. Itagaki, S. Jockusch, J. R. Sparrow, N. J. Turro and K. Nakanishi (2002) Formation of a nonaoxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew. Chem. Int. Ed. Engl. 41(5), 814817.
  • 199
    Sparrow, J. R., J. Zhou, S. Ben-Shabat, H. Vollmer, Y. Itagaki and K. Nakanishi (2002) Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest. Ophthalmol. Vis. Sci. 43(4), 12221227.
  • 200
    Avalle, L. B., Z. Wang, J. P. Dillon and E. R. Gaillard (2004) Observation of A2E oxidation products in human retinal lipofuscin. Exp. Eye Res. 78(4), 895898.
  • 201
    Dillon, J., Z. Wang, L. B. Avalle and E. R. Gaillard (2004) The photochemical oxidation of A2E results in the formation of a 5,8,5′,8′-bis-furanoid oxide. Exp. Eye Res. 79(4), 537542.
  • 202
    Jang, Y. P., H. Matsuda, Y. Itagaki, K. Nakanishi and J. R. Sparrow (2005) Characterization of peroxy-A2E and furan-A2E photooxidation products and detection in human and mouse retinal pigment epithelial cell lipofuscin. J. Biol. Chem. 280(48), 3973239739.
  • 203
    Schutt, F., S. Davies, J. Kopitz, F. G. Holz and M. E. Boulton (2000) Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest. Ophthalmol. Vis. Sci. 41(8), 23032308.
  • 204
    Sparrow, J. R., K. Nakanishi and C. A. Parish (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest. Ophthalmol. Vis. Sci. 41(7), 19811989.
  • 205
    Sparrow, J. R. and B. Cai (2001) Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Vis. Sci. 42(6), 13561362.
  • 206
    Harper, W. S. and E. R. Gaillard (2003) A photochemical study of (E,E,E,E)-2-[9-(2-hydroxyethyl)imino-3,7-dimethyl-1,3,5,7-decatrien-1-yl]- 1,3,3-trimethylcyclohexene, a derivative of all-trans-retinal and ethanolamine. Photochem. Photobiol. 78(3), 298305.
  • 207
    Jockusch, S., R. X. Ren, Y. P. Jang, Y. Itagaki, H. R. Vollmer-Snarr, J. R. Sparrow, K. Nakanishi and N. J. Turro (2004) Photochemistry of A1E, a retinoid with a conjugated pyridinium moiety: competition between pericyclic photooxygenation and pericyclization. J. Am. Chem. Soc. 126(14), 46464652.
  • 208
    Fishkin, N., Y. P. Jang, Y. Itagaki, J. R. Sparrow and K. Nakanishi (2003) A2-rhodopsin: a new fluorophore isolated from photoreceptor outer segments. Org. Biomol. Chem. 1(7), 11011105.
  • 209
    Fishkin, N. E., J. R. Sparrow, R. Allikmets and K. Nakanishi (2005) Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc. Natl. Acad. Sci. U.S.A. 102(20), 70917096.
  • 210
    Kim, S. R., Y. P. Jang, S. Jockusch, N. E. Fishkin, N. J. Turro and J. R. Sparrow (2007) The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc. Natl. Acad. Sci. U.S.A. 104, 1927319278.
  • 211
    Wu, Y., N. E. Fishkin, A. Pande, J. Pande and J. R. Sparrow (2009) Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J. Biol. Chem. 284(30), 2015520166.
  • 212
    Kim, S. R., Y. P. Jang and J. R. Sparrow (2010) Photooxidation of RPE lipofuscin bisretinoids enhances fluorescence intensity. Vision. Res. 50(7), 729736.
  • 213
    Bui, T. V., Y. Han, R. A. Radu, G. H. Travis and N. L. Mata (2006) Characterization of native retinal fluorophores involved in biosynthesis of A2E and lipofuscin-associated retinopathies. J. Biol. Chem. 281(26), 1811218119.
  • 214
    Sparrow, J. R., K. D. Yoon, Y. Wu and K. Yamamoto (2010) Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina. Invest. Ophthalmol. Vis. Sci. 51, 43514357.
  • 215
    Yamamoto, K., K. D. Yoon, K. Ueda, M. Hashimoto and J. R. Sparrow (2011) A novel bisretinoid of retina is an adduct on glycerophosphoethanolamine. Invest. Ophthalmol. Vis. Sci. 52(12), 90849090.
  • 216
    Wang, Z., L. M. Keller, J. Dillon and E. R. Gaillard (2006) Oxidation of A2E results in the formation of highly reactive aldehydes and ketones. Photochem. Photobiol. 82(5), 12511257.
  • 217
    Wu, Y., E. Yanase, X. Feng, M. M. Siegel and J. R. Sparrow (2010) Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 107(16), 72757280.
  • 218
    Zhou, J., Y. P. Jang, S. R. Kim and J. R. Sparrow (2006) Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U.S.A. 103(44), 1618216187.
  • 219
    Kim, S. R., K. Nakanishi, Y. Itagaki and J. R. Sparrow (2006) Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp. Eye Res. 82(5), 828839.
  • 220
    Wihlmark, U., A. Wrigstad, K. Roberg, S. E. Nilsson and U. T. Brunk (1997) Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. Free Radic. Biol. Med. 22(7), 12291234.
  • 221
    Godley, B. F., F. A. Shamsi, F. Q. Liang, S. G. Jarrett, S. Davies and M. Boulton (2005) Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 280(22), 2106121066.
  • 222
    Gottsch, J. D., L. A. Bynoe, J. B. Harlan, E. V. Rencs and W. R. Green (1993) Light-induced deposits in Bruch’s membrane of protoporphyric mice. Arch. Ophthalmol. 111(1), 126129.
  • 223
    Sparrow, J. R., J. Zhou and B. Cai (2003) DNA is a target of the photodynamic effects elicited in A2E-laden RPE by blue-light illumination. Invest. Ophthalmol. Vis. Sci. 44(5), 22452251.
  • 224
    Wirz-Justice, A. (1994) A decade of light therapy for seasonal affective disorder. In Biological Effects of Light (Edited by E. G. Jung and A. M. Kligman), pp. 191205. Walter de Gruyter, New York.
  • 225
    Terman, M., L. Amira, J. S. Terman and D. C. Ross (1996) Predictors of response and nonresponse to light treatment for winter depression. Am. J. Psychiatry 153(11), 14231429.
  • 226
    Schwartz, P. J., C. Brown, T. A. Wehr and N. E. Rosenthal (1996) Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. Am. J. Psychiatry 153(8), 10281036.
  • 227
    Lewy, A. J., H. A. Kern, N. E. Rosenthal and T. A. Wehr (1982) Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am. J. Psychiatry 139(11), 14961498.
  • 228
    Wever, R. A. (1985) Use of light to treat jet lag: differential effects of normal and bright artificial light on human circadian rhythms. Ann. N. Y. Acad. Sci. 453, 282304.
  • 229
    Figueiro, M. G., A. Bierman, J. D. Bullough and M. S. Rea (2009) A personal light-treatment device for improving sleep quality in the elderly: dynamics of nocturnal melatonin suppression at two exposure levels. Chronobiol. Int. 26(4), 726739.
  • 230
    Roberts, J. E. (2010) Circadian rhythm and human health http://www.photobiology.info/Roberts-CR.html .
  • 231
    Cunha-Vaz, J. G. (1980) Blood–retinal barriers in health and disease. Trans. Ophthalmol. Soc. U.K. 100, 337340.
  • 232
    Gomer, C. J., J. V. Jester, N. J. Razum, B. C. Szirth and A. L. Murphree (1985) Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res. 45(8), 37183725.
  • 233
    Tse, D. T., J. J. Dutton, T. A. Weingeist, V. M. Hermsen and R. C. Kersten (1984) Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch. Ophthalmol. 102(6), 833838.
  • 234
    Nishiwaki, H., R. Zeimer, M. F. Goldberg, S. A. D’Anna, S. A. Vinores and R. Grebe (2002) Laser targeted photo-occlusion of rat choroidal neovascularization without collateral damage. Photochem. Photobiol. 75(2), 149158.
  • 235
    Urbańska, K., B. Romanowska-Dixon, M. Elas, S. Pająk, E. Paziewski, J. Bryk, B. Kukiełczak, A. Słomiński, H. Żygulska-Mach and S. Łukiewicz (2000) Experimental ruthenium plaque therapy of amelanotic and melanotic melanomas in the hamster eye. Melanoma Res. 10(1), 2635.
  • 236
    Pece, A., V. Isola, M. Vadala and G. Calori (2007) Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Retina 27, 342348.
  • 237
    Gomi, F., M. Ohji, K. Sayanagi, M. Sawa, H. Sakaguchi, Y. Oshima, Y. Ikuno and Y. Tano (2008) One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 115, 141146.
  • 238
    Incorvaia, C., C. Campa, F. Parmeggiani, M. Menzione, S. D’Angelo, M. Della Corte, M. Rinaldi, M. Romano, R. Dell’omo and C. Costagliola (2008) 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration. Retina 28(2), 289297.
  • 239
    Ferrario, A., A. M. Fisher, N. Rucker and C. J. Gomer (2005) Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 65, 94739478.
  • 240
    Ji, Z. Q., H. F. Sun, H. F. Wang, Q. Y. Xie, Y. F. Liu and Z. Wang (2006) Biodistribution and tumor uptake of C-60(OH)(x) in mice. J. Nanopart. Res. 8, 5363.
  • 241
    Zhao, B., Y. Y. He, C. F. Chignell, J. J. Yin, U. Andley and J. E. Roberts (2009) Difference in phototoxicity of cyclodextrin complexed fullerene [(gamma-CyD)2/C60] and its aggregated derivatives toward human lens epithelial cells. Chem. Res. Toxicol. 22(4), 660667.
  • 242
    Yamago, S., H. Tokuyama, E. Nakamura, K. Kikuchi, S. Kananishi, K. Sueki, H. Nakahara, S. Enomoto and F. Ambe (1995) In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem. Biol. 2, 385389.
  • 243
    Calvo, P., A. Sanchez, J. Martinez, M. I. Lopez, M. Calonge, J. C. Pastor and M. J. Alonso (1996) Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm. Res. 13, 311315.
  • 244
    Dugan, L. L., D. M. Turetsky, C. Du, D. Lobner, M. Wheeler, C. R. Almli, C. K. Shen, T. Y. Luh, D. W. Choi and T. S. Lin (1997) Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. U.S.A. 94, 94349439.
  • 245
    Da Ros, T. and M. Prato (1999) Medicinal chemistry with fullerenes and fullerene derivatives. Chem. Commun. 663669.
  • 246
    Nakamura, E. and H. Isobe (2003) Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc. Chem. Res. 36, 807815.
  • 247
    Prow, T. W., I. Bhutto, R. Grebe, K. Uno, C. Merges, D. S. McLeod and G. A. Lutty (2008) Nanoparticle-delivered biosensor for reactive oxygen species in diabetes. Vision. Res. 48(3), 478485.
  • 248
    Bejjani, R. A., D. BenEzra, H. Cohen, J. Rieger, C. Andrieu, J. C. Jeanny, G. Gollomb and F. F. Behar-Cohen (2005) Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol. Vis. 11, 124132.
  • 249
    Bourges, J. L., S. E. Gautier, F. Delie, R. A. Bejjani, J. C. Jeanny, R. Gurny, D. BenEzra and F. F. Behar-Cohen (2003) Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 44, 35623569.
  • 250
    Roberts, J. E., A. R. Wielgus, W. K. Boyes, U. Andley and C. F. Chignell (2008) Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol. Appl. Pharmacol. 228(1), 4958.
  • 251
    Wielgus, A. R., B. Zhao, C. F. Chignell, D. N. Hu and J. E. Roberts (2010) Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells. Toxicol. Appl. Pharmacol. 242(1), 7990.
  • 252
    Oberdorster, G., E. Oberdorster and J. Oberdorster (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113(7), 823839.
  • 253
    Balbus, J. M., A. D. Maynard, V. L. Colvin, V. Castranova, G. P. Daston, R. A. Denison, K. L. Dreher, P. L. Goering, A. M. Goldberg, K. M. Kulinowski, N. A. Monteiro-Riviere, G. Oberdorster, G. S. Omenn, K. E. Pinkerton, K. S. Ramos, K. M. Rest, J. B. Sass, E. K. Silbergeld and B. A. Wong (2007) Meeting report: hazard assessment for nanoparticles—report from an interdisciplinary workshop. Environ. Health Perspect. 115, 16541659.
  • 254
    Taroni, P., C. D’Andrea, G. Valentini, R. Cubeddu, D. N. Hu and J. E. Roberts (2011) Fullerol in human lens and retinal pigment epithelial cells: time domain fluorescence spectroscopy and imaging. Photochem. Photobiol. Sci. 10(6), 904910.
  • 255
    Zhao, B., J. J. Yin, P. J. Bilski, C. F. Chignell, J. E. Roberts and Y. Y. He (2009) Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol. Appl. Pharmacol. 241(2), 163172.
  • 256
    Sanders, K., L. L. Degn, W. R. Mundy, R. M. Zucker, K. Dreher, B. Zhao, J. E. Roberts and W. K. Boyes (2011) In vitro phototoxicity and hazard identification of nano-scale titanium dioxide. Toxicol. Appl. Pharmacol. 258, 226236.
  • 257
    Vitiello, B. (1999) Hypericum perforatum extracts as potential antidepressants. J. Pharm. Pharmacol. 51, 513517.
  • 258
    Whiskey, E., U. Werneke and D. Taylor (2001) A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int. Clin. Psychopharmacol. 16, 239252.
  • 259
    (2001) Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil. Int. J. Toxicol. 20, 3139.
  • 260
    Higuchi, A. H., H. Yamada, E. Yamada and M. Matsumura (2003) Inhibitory effect of hypericin on retinal and choroidal neovascularization. Invest. Ophtalmol. Vis. Sci. 44, E-Abstract 554.
  • 261
    Harris, M. S., T. Sakamoto, H. Kimura, S. He, C. Spee, R. Gopalakrishna, U. Gundimeda, J. S. Yoo, D. R. Hinton and S. J. Ryan (1996) Hypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase C. Curr. Eye Res. 15, 255262.
  • 262
    Ehrenberg, B., J. L. Anderson and C. S. Foote (1998) Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem. Photobiol. 68, 135140.
  • 263
    Gulick, R. M., V. McAuliffe, J. Holden-Wiltse, C. Crumpacker, L. Liebes, D. S. Stein, P. Meehan, S. Hussey, J. Forcht and F. T. Valentine (1999) Phase I studies of hypericin, the active compound in St. John’s Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann. Intern. Med. 130, 510514.
  • 264
    Cotterill, J. A. (2001) Severe phototoxic reaction to laser treatment in a patient taking St John’s Wort. J. Cosmet. Laser Ther. 3, 159160.
  • 265
    He, Y.-Y., C. F. Chignell, D. S. Miller, U. P. Andley and J. E. Roberts (2004) Phototoxicity in human lens epithelial cells promoted by St. John’s Wort. Photochem. Photobiol. 80, 583586.
  • 266
    Sgarbossa, A., N. Angelini, D. Gioffre, T. Youssef, F. Lenci and J. E. Roberts (2000) The uptake, location and fluorescence of hypericin in bovine intact lens. Curr. Eye Res. 21, 597601.
  • 267
    Taroni, P., G. Valentini, D. Comelli, C. D’Andrea, R. Cubeddu, D.-N. Hu and J. E. Roberts (2005) Time-resolved microspectrofluorimetry and fluorescence lifetime imaging of hypericin in human retinal pigment epithelial cells. Photochem. Photobiol. 81, 524528.
  • 268
    Wielgus, A. R., C. F. Chignell, D. S. Miller, B. Van Houten, J. Meyer, D.-N. Hu and J. E. Roberts (2007) Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John’s Wort. Photochem. Photobiol. 83(3), 706713.
  • 269
    Wu, W.-C., D.-N. Hu and J. E. Roberts (2005) Phototoxicity of indocyanine green on human retinal pigment epithelium in vitro and its reduction by lutein. Photochem. Photobiol. 81, 537540.
  • 270
    Chen, G. and Z. Djuric (2001) Carotenoids are degraded by free radicals but do not affect lipid peroxidation in unilamellar liposomes under different oxygen tensions. FEBS Lett. 505(1), 151154.
  • 271
    Cantrell, A., D. J. McGarvey, T. G. Truscott, F. Rancan and F. Bohm (2003) Singlet oxygen quenching by dietary carotenoids in a model membrane environment. Arch. Biochem. Biophys. 412(1), 4754.
  • 272
    Feher, J., I. Kovacs, M. Artico, C. Cavallotti, A. Papale and C. Balacco Gabrieli (2006) Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 27, 983993.